Down-regulation	O
of	O
BOB.1/OBF.1	B-protein
and	O
Oct2	B-protein
in	O
classical	O
Hodgkin	O
disease	O
but	O
not	O
in	O
lymphocyte	O
predominant	O
Hodgkin	O
disease	O
correlates	O
with	O
immunoglobulin	O
transcription	O
.	O

In	O
contrast	O
to	O
the	O
tumor	B-cell_type
cells	I-cell_type
(	O
L	B-cell_type
&	I-cell_type
H	I-cell_type
cells	I-cell_type
)	O
of	O
lymphocyte	O
predominant	O
Hodgkin	O
disease	O
(	O
LPHD	O
)	O
,	O
Hodgkin	B-cell_type
and	I-cell_type
Reed-Sternberg	I-cell_type
(	I-cell_type
HRS	I-cell_type
)	I-cell_type
cells	I-cell_type
of	O
classical	O
Hodgkin	O
disease	O
(	O
cHD	O
)	O
are	O
unable	O
to	O
transcribe	O
immunoglobulin	B-protein
,	O
despite	O
the	O
presence	O
of	O
rearranged	B-DNA
immunoglobulin	I-DNA
genes	I-DNA
.	O

Although	O
initial	O
studies	O
have	O
suggested	O
crippling	O
immunoglobulin	O
gene	O
mutations	O
to	O
be	O
the	O
cause	O
of	O
absent	O
immunoglobulin	O
expression	O
in	O
cHD	O
,	O
recent	O
work	O
of	O
our	O
group	O
has	O
demonstrated	O
an	O
impaired	O
activation	O
of	O
the	O
immunoglobulin	B-DNA
promoter	I-DNA
as	O
a	O
superior	O
mechanism	O
.	O

As	O
immunoglobulin	O
transcription	O
is	O
mainly	O
regulated	O
by	O
the	O
B-cell	B-protein
transcription	I-protein
factors	I-protein
Oct2	B-protein
and	O
BOB.1/OBF.1	B-protein
,	O
we	O
analyzed	O
35	O
cases	O
of	O
LPHD	O
,	O
32	O
cases	O
of	O
cHD	O
,	O
and	O
2	O
Hodgkin	B-cell_line
disease	I-cell_line
cell	I-cell_line
lines	I-cell_line
for	O
the	O
expression	O
of	O
these	O
transcription	B-protein
factors	I-protein
and	O
also	O
in	O
parallel	O
for	O
immunoglobulin	O
expression	O
.	O

Our	O
results	O
demonstrate	O
an	O
absence	O
of	O
Oct2	B-protein
and/or	O
BOB.1/OBF.1	B-protein
in	O
cHD	O
and	O
a	O
striking	O
overexpression	O
of	O
Oct2	B-protein
in	O
LPHD	O
.	O

Immunoglobulin	O
expression	O
was	O
lacking	O
in	O
cHD	O
but	O
present	O
in	O
LPHD	O
.	O

Furthermore	O
,	O
the	O
reintroduction	O
of	O
BOB.1/OBF.1	B-protein
and	O
Oct2	B-protein
into	O
cultured	O
HRS	B-cell_type
cells	I-cell_type
restored	O
the	O
activity	O
of	O
cotransduced	O
immunoglobulin	B-DNA
promoter	I-DNA
constructs	I-DNA
.	O

Our	O
findings	O
dismiss	O
the	O
concept	O
that	O
the	O
different	O
immunoglobulin	O
expression	O
in	O
cHD	O
and	O
LPHD	O
is	O
due	O
to	O
disrupting	O
mutations	O
of	O
immunoglobulin	B-DNA
V	I-DNA
genes	I-DNA
in	O
cHD	O
but	O
is	O
most	O
likely	O
due	O
to	O
a	O
down-regulation	O
of	O
Oct2	B-protein
and/or	O
BOB.1/OBF.1	B-protein
.	O

This	O
study	O
further	O
revealed	O
Oct2	B-protein
as	O
a	O
new	O
and	O
valuable	O
marker	O
for	O
the	O
identification	O
of	O
L	B-cell_type
&	I-cell_type
H	I-cell_type
cells	I-cell_type
and	O
their	O
distinction	O
from	O
HRS	B-cell_type
cells	I-cell_type
.	O

The	O
impairment	O
of	O
immunoglobulin	O
transcription	O
with	O
a	O
down-regulated	O
synthesis	O
of	O
Oct2	B-protein
and	O
BOB.1/OBF.1	B-protein
is	O
the	O
first	O
established	O
general	O
recurrent	O
defect	O
found	O
in	O
HRS	B-cell_type
cells	I-cell_type
.	O

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

NEOPLASIA	NULL
Down-regulation	NULL
of	NULL
BOB.1/0BF.1	NULL
and	NULL
Oct2	NULL
in	NULL
classical	NULL
Hodgkin	NULL
disease	NULL
but	NULL
not	NULL
in	NULL
lymphocyte	NULL
predominant	NULL
Hodgkin	NULL
disease	NULL
correlates	NULL
with	NULL
immunoglobulin	NULL
transcription	NULL
Harald	NULL
Stein	NULL
,	NULL
Theresa	NULL
Marafioti	NULL
,	NULL
Hans-Dieter	NULL
Foss	NULL
,	NULL
Helmut	NULL
Laumen	NULL
,	NULL
Michael	NULL
Hummel	NULL
,	NULL
Ioannis	NULL
Anagnostopoulos	NULL
,	NULL
Thomas	NULL
Wirth	NULL
,	NULL
Gudrun	NULL
Demel	NULL
,	NULL
and	NULL
Brunangelo	NULL
Falini	NULL
In	NULL
contrast	NULL
to	NULL
the	NULL
tumor	NULL
cells	NULL
(	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
)	NULL
of	NULL
lymphocyte	NULL
predominant	NULL
Hodgkin	NULL
disease	NULL
(	NULL
LPHD	NULL
)	NULL
,	NULL
Hodgkin	NULL
and	NULL
Reed-Sternberg	NULL
(	NULL
HRS	NULL
)	NULL
cells	NULL
of	NULL
classical	NULL
Hodgkin	NULL
disease	NULL
(	NULL
cHD	NULL
)	NULL
are	NULL
unable	NULL
to	NULL
transcribe	NULL
immunoglobulin	NULL
,	NULL
despite	NULL
the	NULL
presence	NULL
of	NULL
rearranged	NULL
immunoglobulin	NULL
genes	NULL
.	NULL

Although	NULL
initial	NULL
studies	NULL
have	NULL
suggested	NULL
crippling	NULL
immunoglobulin	NULL
gene	NULL
mutations	NULL
to	NULL
be	NULL
the	NULL
cause	NULL
of	NULL
absent	NULL
immunoglobulin	NULL
expression	NULL
in	NULL
cHD	NULL
,	NULL
recent	NULL
work	NULL
of	NULL
our	NULL
group	NULL
has	NULL
demonstrated	NULL
an	NULL
impaired	NULL
activation	NULL
of	NULL
the	NULL
immunoglobulin	NULL
promoter	NULL
as	NULL
a	NULL
superior	NULL
mechanism	NULL
.	NULL

As	NULL
immunoglobulin	NULL
transcription	NULL
is	NULL
mainly	NULL
regulated	NULL
by	NULL
the	NULL
B-cell	NULL
transcription	NULL
fac-	NULL
tors	NULL
Oct2	NULL
and	NULL
BOB.1/0BF.1	NULL
,	NULL
we	NULL
analyzed	NULL
35	NULL
cases	NULL
of	NULL
LPHD	NULL
,	NULL
32	NULL
cases	NULL
of	NULL
cHD	NULL
,	NULL
and	NULL
2	NULL
Hodgkin	NULL
disease	NULL
cell	NULL
lines	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
and	NULL
also	NULL
in	NULL
parallel	NULL
for	NULL
immunoglobulin	NULL
expression	NULL
.	NULL

Our	NULL
results	NULL
demonstrate	NULL
an	NULL
absence	NULL
of	NULL
Oct2	NULL
and/or	NULL
BOB.1/0BF.1	NULL
in	NULL
cHD	NULL
and	NULL
a	NULL
striking	NULL
overexpression	NULL
of	NULL
Oct2	NULL
in	NULL
LPHD	NULL
.	NULL

Immunoglobulin	NULL
expression	NULL
was	NULL
lacking	NULL
in	NULL
cHD	NULL
but	NULL
present	NULL
in	NULL
LPHD	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
reintroduction	NULL
of	NULL
BOB.1/	NULL
OBF.1	NULL
and	NULL
Oct2	NULL
into	NULL
cultured	NULL
HRS	NULL
cells	NULL
restored	NULL
the	NULL
activity	NULL
of	NULL
cotransduced	NULL
immunoglobulin	NULL
promoter	NULL
constructs	NULL
.	NULL

Our	NULL
findings	NULL
dismiss	NULL
the	NULL
concept	NULL
that	NULL
the	NULL
different	NULL
immunoglobulin	NULL
expression	NULL
in	NULL
cHD	NULL
and	NULL
LPHD	NULL
is	NULL
due	NULL
to	NULL
disrupting	NULL
mutations	NULL
of	NULL
immunoglobulin	NULL
V	NULL
genes	NULL
in	NULL
cHD	NULL
but	NULL
is	NULL
most	NULL
likely	NULL
due	NULL
to	NULL
a	NULL
down-regulation	NULL
of	NULL
Oct2	NULL
and/or	NULL
BOB.1/0BF.1	NULL
.	NULL

This	NULL
study	NULL
further	NULL
revealed	NULL
Oct2	NULL
as	NULL
a	NULL
new	NULL
and	NULL
valuable	NULL
marker	NULL
for	NULL
the	NULL
identification	NULL
of	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
and	NULL
their	NULL
distinction	NULL
from	NULL
HRS	NULL
cells	NULL
.	NULL

The	NULL
impairment	NULL
of	NULL
immunoglobulin	NULL
transcription	NULL
with	NULL
a	NULL
down-regulated	NULL
synthesis	NULL
of	NULL
Oct2	NULL
and	NULL
BOB.1/0BF.1	NULL
is	NULL
the	NULL
first	NULL
established	NULL
general	NULL
recurrent	NULL
defect	NULL
found	NULL
in	NULL
HRS	NULL
cells	NULL
.	NULL

(	NULL
Blood	NULL
.	NULL

2001	NULL
;	NULL
97	NULL
:	NULL
496-501	NULL
)	NULL
©2001	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
Introduction	NULL
Hodgkin	NULL
disease	NULL
(	NULL
HD	NULL
)	NULL
is	NULL
one	NULL
of	NULL
the	NULL
most	NULL
common	NULL
categories	NULL
of	NULL
malignant	NULL
lymphoma	NULL
in	NULL
Europe	NULL
and	NULL
North	NULL
America	NULL
.	NULL

Two	NULL
distinct	NULL
types	NULL
,	NULL
the	NULL
rare	NULL
lymphocyte	NULL
predominant	NULL
(	NULL
LPHD	NULL
)	NULL
form	NULL
and	NULL
the	NULL
common	NULL
classical	NULL
form	NULL
(	NULL
cHD	NULL
)	NULL
,	NULL
have	NULL
been	NULL
distinguished	NULL
.	NULL

LPHD	NULL
and	NULL
cHD	NULL
have	NULL
both	NULL
common	NULL
features	NULL
and	NULL
marked	NULL
differences	NULL
.	NULL

The	NULL
features	NULL
that	NULL
they	NULL
have	NULL
in	NULL
common	NULL
are	NULL
(	NULL
1	NULL
)	NULL
a	NULL
few	NULL
large	NULL
tumor	NULL
cells	NULL
in	NULL
an	NULL
abundant	NULL
admixture	NULL
of	NULL
non-neoplastic	NULL
inflammatory	NULL
cells	NULL
,	NULL
(	NULL
2	NULL
)	NULL
T-cell	NULL
rosettes	NULL
around	NULL
the	NULL
tumor	NULL
cells	NULL
,	NULL
(	NULL
3	NULL
)	NULL
a	NULL
high	NULL
proliferation	NULL
rate	NULL
,	NULL
and	NULL
(	NULL
4	NULL
)	NULL
the	NULL
presence	NULL
of	NULL
clonal	NULL
immunoglobulin	NULL
gene	NULL
rearrangements	NULL
in	NULL
the	NULL
tumor	NULL
cells	NULL
(	NULL
5	NULL
)	NULL
with	NULL
a	NULL
high	NULL
load	NULL
of	NULL
somatic	NULL
mutations	NULL
.	NULL

The	NULL
features	NULL
that	NULL
differentiate	NULL
them	NULL
mainly	NULL
concern	NULL
the	NULL
gene	NULL
expression	NULL
of	NULL
the	NULL
tumor	NULL
cells	NULL
.	NULL

In	NULL
LPHD	NULL
the	NULL
tumor	NULL
cells	NULL
(	NULL
designated	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
)	NULL
constantly	NULL
express	NULL
B-cell-associated	NULL
molecules	NULL
(	NULL
eg	NULL
,	NULL
€D20	NULL
,	NULL
CD792	NULL
,	NULL
J-chain	NULL
,	NULL
and	NULL
immunoglobulin	NULL
transcripts	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
CD30	NULL
and	NULL
CD15	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
tumor	NULL
cells	NULL
of	NULL
cHD	NULL
(	NULL
termed	NULL
Hodgkin	NULL
and	NULL
Reed-Sternberg	NULL
[	NULL
HRS	NULL
]	NULL
cells	NULL
)	NULL
carry	NULL
CD30	NULL
and	NULL
CD15	NULL
but	NULL
lack	NULL
CD20	NULL
,	NULL
CD79a	NULL
,	NULL
J-chain	NULL
,	NULL
and	NULL
immunoglobulin	NULL
transcripts	NULL
in	NULL
most	NULL
or	NULL
all	NULL
instances	NULL
(	NULL
reviewed	NULL
by	NULL
Stein	NULL
et	NULL
al	NULL
!	NULL

and	NULL
Anagnostopoulos	NULL
et	NULL
al2	NULL
)	NULL
.	NULL

The	NULL
different	NULL
immunoglobulin	NULL
expression	NULL
has	NULL
raised	NULL
particular	NULL
interest	NULL
because	NULL
the	NULL
tumor	NULL
cells	NULL
of	NULL
both	NULL
LPHD	NULL
and	NULL
cHD	NULL
contain	NULL
rearranged	NULL
immunoglobulin	NULL
genes	NULL
.	NULL
``	NULL

This	NULL
differ	NULL
ence	NULL
was	NULL
explained	NULL
by	NULL
Rajewsky	NULL
and	NULL
colleagues	NULL
``	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
intact	NULL
immunoglobulin	NULL
gene	NULL
coding	NULL
sequences	NULL
in	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
and	NULL
crippled	NULL
immunoglobulin	NULL
genes	NULL
in	NULL
HRS	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
this	NULL
,	NULL
our	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
immunoglobulin	NULL
gene	NULL
coding	NULL
capacity	NULL
is	NULL
intact	NULL
not	NULL
only	NULL
in	NULL
LPHD	NULL
but	NULL
also	NULL
in	NULL
the	NULL
majority	NULL
of	NULL
cHD	NULL
cases	NULL
,	NULL
``	NULL
prompting	NULL
the	NULL
conclusion	NULL
that	NULL
the	NULL
absent	NULL
immunoglobulin	NULL
expression	NULL
in	NULL
HRS	NULL
cells	NULL
is	NULL
due	NULL
to	NULL
a	NULL
defect	NULL
in	NULL
the	NULL
transcription	NULL
machinery	NULL
rather	NULL
than	NULL
to	NULL
a	NULL
disruption	NULL
of	NULL
the	NULL
immunoglobulin	NULL
genes	NULL
themselves	NULL
.	NULL

This	NULL
was	NULL
confirmed	NULL
by	NULL
our	NULL
recent	NULL
transfection	NULL
studies	NULL
which	NULL
showed	NULL
that	NULL
immunoglobulin	NULL
gene	NULL
promoter	NULL
luciferase	NULL
reporter	NULL
constructs	NULL
exhibited	NULL
no	NULL
activity	NULL
in	NULL
cultured	NULL
HRS	NULL
cells	NULL
.	NULL

The	NULL
transcription	NULL
factors	NULL
Octl	NULL
and	NULL
Oct2	NULL
and	NULL
their	NULL
coactivator	NULL
BOB.1/0OBF.1	NULL
regulate	NULL
immunoglobulin	NULL
gene	NULL
transcription	NULL
.	NULL

Octl	NULL
and	NULL
Oct2	NULL
bind	NULL
to	NULL
the	NULL
immunoglobulin	NULL
gene	NULL
promoter	NULL
octamer	NULL
motif	NULL
and	NULL
activate	NULL
immunoglobulin	NULL
gene	NULL
transcription	NULL
when	NULL
the	NULL
coactivator	NULL
BOB.1/0BF.1	NULL
is	NULL
recruited	NULL
into	NULL
the	NULL
transcription	NULL
complex	NULL
.	NULL
``	NULL

BOB.1/OBE.1	NULL
was	NULL
also	NULL
shown	NULL
to	NULL
act	NULL
as	NULL
a	NULL
molecular	NULL
clamp	NULL
that	NULL
holds	NULL
together	NULL
the	NULL
POU	NULL
subdomains	NULL
of	NULL
Octl	NULL
or	NULL
Oct2	NULL
.	NULL
``	NULL

Finally	NULL
,	NULL
according	NULL
to	NULL
knockout	NULL
experiments	NULL
performed	NULL
,	NULL
Octl	NULL
and	NULL
Oct2	NULL
can	NULL
replace	NULL
each	NULL
other	NULL
,	NULL
whereas	NULL
BOB.1/0BF.1	NULL
is	NULL
unconditionally	NULL
required	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
From	NULL
the	NULL
Institute	NULL
of	NULL
Pathology	NULL
,	NULL
Consultation	NULL
and	NULL
Reference	NULL
Centre	NULL
for	NULL
Lymph	NULL
Node	NULL
Pathology	NULL
and	NULL
Haematopathology	NULL
,	NULL
University	NULL
Hospital	NULL
Benjamin	NULL
Franklin	NULL
,	NULL
Free	NULL
University	NULL
,	NULL
Berlin	NULL
,	NULL
Germany	NULL
;	NULL
Department	NULL
of	NULL
Physiological	NULL
Chemistry	NULL
,	NULL
Universitat	NULL
UIm	NULL
,	NULL
Germany	NULL
;	NULL
and	NULL
Istituto	NULL
di	NULL
Ematologia	NULL
,	NULL
Universita	NULL
'	NULL
di	NULL
Perugia	NULL
,	NULL
Perugia	NULL
,	NULL
Italy	NULL
.	NULL

Submitted	NULL
May	NULL
31	NULL
,	NULL
2000	NULL
;	NULL
accepted	NULL
September	NULL
15	NULL
,	NULL
2000	NULL
.	NULL

Supported	NULL
by	NULL
grants	NULL
of	NULL
the	NULL
Deutsche	NULL
Forschungsgemeinschaft	NULL
and	NULL
Deutsche	NULL
Krebshilfe	NULL
,	NULL
AIRC	NULL
(	NULL
Associazione	NULL
Italiana	NULL
per	NULL
la	NULL
Ricerca	NULL
sul	NULL
Cancro	NULL
)	NULL
,	NULL
and	NULL
MURST	NULL
.	NULL

496	NULL
Reprints	NULL
:	NULL
Harald	NULL
Stein	NULL
,	NULL
Institute	NULL
of	NULL
Pathology	NULL
,	NULL
Benjamin	NULL
Franklin	NULL
University	NULL
Hospital	NULL
,	NULL
Free	NULL
University	NULL
Berlin	NULL
,	NULL
Hindenburgdamm	NULL
30	NULL
,	NULL
12200	NULL
Berlin	NULL
,	NULL
Germany	NULL
;	NULL
e-mail	NULL
:	NULL
stein	NULL
@	NULL
ukbf.fu-berlin.de	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

Therefore	NULL
,	NULL
and	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
,	NULL
this	NULL
article	NULL
is	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
.	NULL

©2001	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
BLOOD	NULL
,	NULL
15	NULL
JANUARY	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
2	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

BLOOD	NULL
,	NULL
15	NULL
JANUARY	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
2	NULL
the	NULL
immunoglobulin	NULL
gene	NULL
promoter	NULL
.	NULL
``	NULL

This	NULL
implies	NULL
that	NULL
Oct1	NULL
and	NULL
Oct2	NULL
or	NULL
their	NULL
coactivator	NULL
BOB.1/0BF.1	NULL
are	NULL
regularly	NULL
expressed	NULL
in	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
but	NULL
are	NULL
absent	NULL
from	NULL
,	NULL
or	NULL
are	NULL
defective	NULL
in	NULL
,	NULL
HRS	NULL
cells	NULL
.	NULL

This	NULL
paper	NULL
reports	NULL
on	NULL
studies	NULL
designed	NULL
to	NULL
check	NULL
this	NULL
claim	NULL
.	NULL

The	NULL
results	NULL
obtained	NULL
confirm	NULL
the	NULL
claim	NULL
concerning	NULL
the	NULL
absence	NULL
of	NULL
Oct2	NULL
and/or	NULL
BOB.1/O0BF.1	NULL
in	NULL
HRS	NULL
cells	NULL
with	NULL
the	NULL
additional	NULL
interesting	NULL
observation	NULL
that	NULL
Oct2	NULL
is	NULL
enormously	NULL
overexpressed	NULL
by	NULL
the	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
.	NULL

These	NULL
findings	NULL
,	NULL
in	NULL
association	NULL
with	NULL
our	NULL
demonstration	NULL
of	NULL
the	NULL
restoration	NULL
of	NULL
the	NULL
immunoglobulin	NULL
promoter	NULL
activity	NULL
by	NULL
cotransfection	NULL
of	NULL
BOB.1/0BF.1	NULL
and	NULL
Oct2	NULL
into	NULL
cultured	NULL
HRS	NULL
cells	NULL
,	NULL
strengthen	NULL
our	NULL
hypothesis	NULL
that	NULL
the	NULL
non-expression	NULL
of	NULL
immunoglobulin	NULL
by	NULL
HRS	NULL
cells	NULL
is	NULL
caused	NULL
by	NULL
a	NULL
down-regulated	NULL
synthesis	NULL
of	NULL
immunoglobulin	NULL
transcription	NULL
factors	NULL
required	NULL
for	NULL
immunoglobulin	NULL
transcription	NULL
rather	NULL
than	NULL
by	NULL
crippling	NULL
mutations	NULL
of	NULL
immunoglobulin	NULL
genes	NULL
.	NULL

Our	NULL
findings	NULL
also	NULL
add	NULL
more	NULL
knowledge	NULL
to	NULL
the	NULL
molecular	NULL
differences	NULL
found	NULL
between	NULL
LPHD	NULL
and	NULL
cHD	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
overexpression	NULL
of	NULL
Oct2	NULL
in	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
is	NULL
a	NULL
new	NULL
and	NULL
valuable	NULL
feature	NULL
for	NULL
their	NULL
distinction	NULL
from	NULL
classical	NULL
HRS	NULL
cells	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
Tissues	NULL
and	NULL
cell	NULL
lines	NULL
Paraffin-embedded	NULL
tissue	NULL
samples	NULL
from	NULL
35	NULL
cases	NULL
of	NULL
LPHD	NULL
,	NULL
32	NULL
cases	NULL
of	NULL
cHD	NULL
,	NULL
6	NULL
of	NULL
which	NULL
had	NULL
previously	NULL
been	NULL
investigated	NULL
by	NULL
single-cell	NULL
analysis	NULL
,	NULL
*	NULL
and	NULL
8	NULL
cases	NULL
of	NULL
follicular	NULL
center	NULL
lymphoma	NULL
were	NULL
taken	NULL
from	NULL
the	NULL
files	NULL
of	NULL
the	NULL
Institute	NULL
of	NULL
Pathology	NULL
,	NULL
University	NULL
Hospital	NULL
Benjamin	NULL
Franklin	NULL
of	NULL
the	NULL
Free	NULL
University	NULL
of	NULL
Berlin	NULL
.	NULL

All	NULL
cases	NULL
were	NULL
diagnosed	NULL
according	NULL
to	NULL
the	NULL
Revised	NULL
European-American	NULL
Lymphoma	NULL
Classification	NULL
.	NULL

The	NULL
HD-derived	NULL
cell	NULL
lines	NULL
L428	NULL
and	NULL
KM-H2	NULL
``	NULL
and	NULL
the	NULL
control	NULL
B-cell	NULL
lines	NULL
B-JAB	NULL
,	NULL
Raji	NULL
,	NULL
Jok-1	NULL
,	NULL
and	NULL
DG75	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
,	NULL
antibiotics	NULL
,	NULL
glutamate	NULL
,	NULL
and	NULL
50	NULL
mM	NULL
B-mercaptocethanol	NULL
at	NULL
37°C	NULL
and	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
.	NULL

Immunohistochemistry	NULL
Five-micrometer	NULL
thick	NULL
sections	NULL
of	NULL
paraffin-embedded	NULL
tissue	NULL
blocks	NULL
were	NULL
immunostained	NULL
by	NULL
the	NULL
immunoalkaline-phosphatase	NULL
(	NULL
APAAP	NULL
)	NULL
method	NULL
.	NULL
``	NULL

The	NULL
following	NULL
antibody	NULL
panel	NULL
was	NULL
used	NULL
:	NULL
CD20	NULL
(	NULL
L26	NULL
)	NULL
,	NULL
CD79a	NULL
(	NULL
JCB117	NULL
)	NULL
,	NULL
CD30	NULL
(	NULL
Ber-H2	NULL
)	NULL
,	NULL
CD15	NULL
(	NULL
C3D1	NULL
)	NULL
and	NULL
anti-LMP1	NULL
(	NULL
CS1-4	NULL
)	NULL
,	NULL
polyclonal	NULL
CD3	NULL
,	NULL
anti-immunoglobulin	NULL
M	NULL
(	NULL
IgM	NULL
)	NULL
,	NULL
anti-IgD	NULL
,	NULL
anti-IgG	NULL
(	NULL
DAKO	NULL
,	NULL
Glostrup	NULL
,	NULL
Denmark	NULL
)	NULL
,	NULL
and	NULL
the	NULL
anti-J-chain	NULL
antibody	NULL
(	NULL
Biogenex	NULL
,	NULL
San	NULL
Ramon	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
monoclonal	NULL
antibody	NULL
to	NULL
Oct1	NULL
(	NULL
clone	NULL
12F11	NULL
)	NULL
and	NULL
polyclonal	NULL
antibodies	NULL
to	NULL
Oct2	NULL
and	NULL
BOB.1/0BE.1	NULL
were	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
.	NULL

All	NULL
these	NULL
primary	NULL
antibodies	NULL
were	NULL
applied	NULL
to	NULL
dewaxed	NULL
sections	NULL
that	NULL
were	NULL
pretreated	NULL
by	NULL
heating	NULL
in	NULL
citrate	NULL
buffer	NULL
(	NULL
10	NULL
mMol	NULL
,	NULL
pH	NULL
6.0	NULL
,	NULL
2	NULL
minutes	NULL
)	NULL
in	NULL
a	NULL
pressure	NULL
cooker	NULL
.	NULL

For	NULL
the	NULL
detection	NULL
of	NULL
the	NULL
bound	NULL
antibodies	NULL
either	NULL
the	NULL
APAAP	NULL
method	NULL
or	NULL
the	NULL
streptavidin-bictin	NULL
method	NULL
was	NULL
employed	NULL
.	NULL

In	NULL
situ	NULL
hybridization	NULL
The	NULL
detection	NULL
of	NULL
messenger	NULL
RNA	NULL
(	NULL
mRNA	NULL
)	NULL
for	NULL
Ig	NULL
,	NULL
Ig8	NULL
,	NULL
Igy	NULL
,	NULL
Igx	NULL
,	NULL
IgA	NULL
,	NULL
and	NULL
Oct2	NULL
was	NULL
carried	NULL
out	NULL
,	NULL
using	NULL
a	NULL
highly	NULL
sensitive	NULL
radioactive	NULL
in	NULL
situ	NULL
hybridization	NULL
method	NULL
as	NULL
previously	NULL
described	NULL
.	NULL

*	NULL
``	NULL
``	NULL
The	NULL
Oct2	NULL
probe	NULL
was	NULL
prepared	NULL
from	NULL
complementary	NULL
DNA	NULL
(	NULL
cDNA	NULL
)	NULL
that	NULL
had	NULL
been	NULL
amplified	NULL
by	NULL
reverse	NULL
transcriptase-polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
RT-PCR	NULL
)	NULL
from	NULL
a	NULL
B-cell	NULL
line	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
appropriate	NULL
plasmids	NULL
.	NULL

After	NULL
linearization	NULL
of	NULL
the	NULL
plasmids	NULL
with	NULL
restriction	NULL
enzymes	NULL
,	NULL
anti-sense	NULL
and	NULL
sense	NULL
(	NULL
control	NULL
)	NULL
transcripts	NULL
were	NULL
generated	NULL
,	NULL
using	NULL
T7	NULL
or	NULL
SP6	NULL
RNA-polymerase	NULL
with	NULL
the	NULL
incorporation	NULL
of	NULL
[	NULL
*S	NULL
]	NULL
-dUTP	NULL
.	NULL

Cells	NULL
with	NULL
a	NULL
4-fold	NULL
signal	NULL
intensity	NULL
,	NULL
as	NULL
compared	NULL
to	NULL
background	NULL
signal	NULL
,	NULL
were	NULL
scored	NULL
positive	NULL
.	NULL

Hybridization	NULL
with	NULL
sense-transcripts	NULL
showed	NULL
only	NULL
very	NULL
few	NULL
homogeneously	NULL
distributed	NULL
background	NULL
signals	NULL
.	NULL

TRANSCRIPTION	NULL
FACTORS	NULL
IN	NULL
HODGKIN	NULL
DISEASE	NULL
-	NULL
497	NULL
Northern	NULL
and	NULL
Western	NULL
blot	NULL
analyses	NULL
Total	NULL
cytoplasmic	NULL
RNA	NULL
was	NULL
prepared	NULL
and	NULL
analyzed	NULL
as	NULL
described	NULL
else-where	NULL
.	NULL

'*	NULL
``	NULL
``	NULL
Western	NULL
blot	NULL
analysis	NULL
was	NULL
carried	NULL
out	NULL
according	NULL
to	NULL
previously	NULL
published	NULL
protocols	NULL
.	NULL

!	NULL
``	NULL

Cell	NULL
culture	NULL
and	NULL
transfection	NULL
For	NULL
electroporation	NULL
,	NULL
5	NULL
X	NULL
10°	NULL
cultured	NULL
cells	NULL
were	NULL
pelleted	NULL
and	NULL
resuspended	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
300	NULL
.L	NULL
RPMI	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
.	NULL

Fifteen	NULL
micrograms	NULL
of	NULL
the	NULL
respective	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
(	NULL
details	NULL
about	NULL
the	NULL
wild-type	NULL
immunoglobulin	NULL
octamer	NULL
enhancer	NULL
and	NULL
the	NULL
synthetic	NULL
multimerized	NULL
octamer	NULL
reporter	NULL
constructs	NULL
can	NULL
be	NULL
found	NULL
in	NULL
Laumen	NULL
et	NULL
al	NULL
'	NULL
and	NULL
Pfisterer	NULL
et	NULL
al	NULL
'	NULL
``	NULL
)	NULL
were	NULL
added	NULL
to	NULL
the	NULL
cells	NULL
.	NULL

The	NULL
mixture	NULL
was	NULL
transferred	NULL
to	NULL
a	NULL
cuvette	NULL
with	NULL
a	NULL
gap	NULL
of	NULL
0.4	NULL
em	NULL
and	NULL
electroporated	NULL
at	NULL
230	NULL
V	NULL
and	NULL
950	NULL
F	NULL
with	NULL
a	NULL
Gene	NULL
Pulser	NULL
(	NULL
Biorad	NULL
,	NULL
Munich	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
immediately	NULL
transferred	NULL
to	NULL
a	NULL
Petri	NULL
dish	NULL
containing	NULL
10	NULL
mL	NULL
RPMI/10	NULL
%	NULL
FCS	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
in	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
for	NULL
20	NULL
hours	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
harvested	NULL
,	NULL
and	NULL
the	NULL
lysates	NULL
were	NULL
analyzed	NULL
with	NULL
a	NULL
dual-luciferase	NULL
reporter	NULL
assay	NULL
system	NULL
(	NULL
Promega	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

All	NULL
luciferase	NULL
values	NULL
were	NULL
calculated	NULL
against	NULL
the	NULL
renilla-luciferase	NULL
values	NULL
to	NULL
correct	NULL
for	NULL
different	NULL
transfection	NULL
efficiencies	NULL
.	NULL

Results	NULL
Expression	NULL
of	NULL
immunoglobulin	NULL
in	NULL
cHD	NULL
and	NULL
LPHD	NULL
The	NULL
expression	NULL
of	NULL
immunoglobulin	NULL
in	NULL
classical	NULL
HRS	NULL
cells	NULL
and	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
was	NULL
investigated	NULL
by	NULL
radioactive	NULL
in	NULL
situ	NULL
hybridization	NULL
and	NULL
immunohistochemistry	NULL
.	NULL

As	NULL
in	NULL
a	NULL
previous	NULL
study	NULL
,	NULL
*	NULL
there	NULL
were	NULL
no	NULL
immunoglobulin-specific	NULL
transcripts	NULL
demonstrable	NULL
in	NULL
the	NULL
HRS	NULL
cells	NULL
of	NULL
25	NULL
cases	NULL
of	NULL
cHD	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

This	NULL
result	NULL
held	NULL
true	NULL
even	NULL
when	NULL
the	NULL
exposure	NULL
time	NULL
was	NULL
prolonged	NULL
considerably	NULL
,	NULL
and	NULL
the	NULL
internal	NULL
control	NULL
cells	NULL
(	NULL
plasma	NULL
cells	NULL
and	NULL
B	NULL
cells	NULL
)	NULL
became	NULL
very	NULL
intensely	NULL
positive	NULL
.	NULL

Immunostaining	NULL
with	NULL
immunoglobulin-specific	NULL
antibodies	NULL
often	NULL
produced	NULL
a	NULL
cytoplasmic	NULL
labeling	NULL
of	NULL
many	NULL
HRS	NULL
cells	NULL
.	NULL

The	NULL
staining	NULL
,	NULL
however	NULL
,	NULL
spared	NULL
the	NULL
nuclear	NULL
space	NULL
of	NULL
most	NULL
HRS	NULL
cells	NULL
although	NULL
this	NULL
space	NULL
was	NULL
strongly	NULL
positive	NULL
in	NULL
the	NULL
bystander	NULL
B	NULL
lymphocytes	NULL
and	NULL
plasma	NULL
cells	NULL
in	NULL
all	NULL
instances	NULL
.	NULL

As	NULL
revealed	NULL
by	NULL
Northern	NULL
blotting	NULL
and	NULL
Table	NULL
1	NULL
.	NULL

Expression	NULL
of	NULL
immunoglobulin	NULL
and	NULL
immunoglobulin	NULL
transcription	NULL
factors	NULL
in	NULL
the	NULL
tumor	NULL
cells	NULL
of	NULL
classical	NULL
and	NULL
lymphocyte	NULL
predominant	NULL
Hodgkin	NULL
disease	NULL
HRS	NULL
cells	NULL
of	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
of	NULL
Follicular	NULL
classical	NULL
HD	NULL
LPHD	NULL
lymphoma	NULL
CD30	NULL
32/32	NULL
0/35	NULL
0/8	NULL
CD20	NULL
6/32	NULL
35/35	NULL
8/8	NULL
J-chain	NULL
4*/32	NULL
31/35	NULL
6/8	NULL
Immunoglobulin	NULL
mRNA	NULL
0/25t	NULL
25/27	NULL
8/8	NULL
Immunoglobulin	NULL
protein	NULL
0/25¢	NULL
26/32	NULL
8/8	NULL
Oct2-mRNA	NULL
2§/11	NULL
6/6	NULL
4/4	NULL
Oct2-protein	NULL
4/32	NULL
]	NULL
35/35	NULL
8/8	NULL
BOB.1	NULL
8/32	NULL
]	NULL
35/35	NULL
8/8	NULL
HRS	NULL
cells	NULL
indicates	NULL
Hodgkin	NULL
and	NULL
Reed-Sternberg	NULL
cells	NULL
;	NULL
HD	NULL
,	NULL
Hodgkin	NULL
disease	NULL
;	NULL
LPHD	NULL
,	NULL
lymphocyte	NULL
predominant	NULL
Hodgkin	NULL
disease	NULL
;	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
,	NULL
lymphocytic/histiocytic	NULL
tumor	NULL
cells	NULL
of	NULL
LPHD	NULL
:	NULL
Ig	NULL
,	NULL
immunoglobulin	NULL
;	NULL
mRNA	NULL
,	NULL
messenger	NULL
RNA	NULL
.	NULL

*Very	NULL
weak	NULL
labeling	NULL
.	NULL

tOne	NULL
case	NULL
with	NULL
very	NULL
weak	NULL
signals	NULL
for	NULL
Igk	NULL
in	NULL
some	NULL
HRS	NULL
cells	NULL
.	NULL

$	NULL
Most	NULL
cases	NULL
showed	NULL
in	NULL
some	NULL
or	NULL
many	NULL
HRS	NULL
cells	NULL
immunoreactivity	NULL
with	NULL
antibodies	NULL
to	NULL
IgG	NULL
,	NULL
Ig	NULL
,	NULL
and	NULL
Iga	NULL
.	NULL

However	NULL
,	NULL
in	NULL
the	NULL
majority	NULL
of	NULL
the	NULL
cases	NULL
the	NULL
immune	NULL
reaction	NULL
did	NULL
not	NULL
include	NULL
the	NULL
nuclear	NULL
space	NULL
of	NULL
the	NULL
HRS	NULL
cells	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
B	NULL
cells	NULL
and	NULL
plasma	NULL
cells	NULL
that	NULL
showed	NULL
a	NULL
strong	NULL
nuclear	NULL
space	NULL
staining	NULL
for	NULL
one	NULL
IgL	NULL
chain	NULL
type	NULL
in	NULL
all	NULL
instances	NULL
;	NULL
in	NULL
a	NULL
few	NULL
cases	NULL
there	NULL
was	NULL
a	NULL
nuclear	NULL
space	NULL
staining	NULL
in	NULL
some	NULL
of	NULL
the	NULL
HRS	NULL
cells	NULL
.	NULL

§These	NULL
cases	NULL
also	NULL
expressed	NULL
Oct2	NULL
at	NULL
the	NULL
protein	NULL
level	NULL
.	NULL

In	NULL
only	NULL
one	NULL
case	NULL
all	NULL
HRS	NULL
cells	NULL
were	NULL
positive	NULL
.	NULL

[	NULL
There	NULL
were	NULL
no	NULL
classical	NULL
HD	NULL
cases	NULL
in	NULL
which	NULL
HRS	NULL
cells	NULL
expressed	NULL
both	NULL
Oct2	NULL
and	NULL
BOB.1/OBF.1	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

498	NULL
_	NULL
STEIN	NULL
etal	NULL
Table	NULL
2	NULL
.	NULL

Expression	NULL
of	NULL
immunoglobulin	NULL
,	NULL
Oct1	NULL
,	NULL
Oct2	NULL
,	NULL
and	NULL
BOB.1/0BF.1	NULL
in	NULL
classical	NULL
Hodgkin	NULL
disease-derived	NULL
cell	NULL
lines	NULL
and	NULL
B-cell	NULL
lines	NULL
BLOOD	NULL
,	NULL
15	NULL
JANUARY	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
2	NULL
Table	NULL
3	NULL
.	NULL

Expression	NULL
of	NULL
immunoglobulin	NULL
isotypes	NULL
by	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
of	NULL
lymphocyte	NULL
predominant	NULL
Hodgkin	NULL
disease	NULL
B-cell	NULL
Transcripts	NULL
and	NULL
proteins	NULL
L428	NULL
KM-H2	NULL
lines*	NULL
Immunoglobulin	NULL
mRNAt	NULL
-	NULL
-	NULL
+	NULL
Immunoglobulin	NULL
protein	NULL
}	NULL
-	NULL
Oct1	NULL
mRNAt§	NULL
Oct1	NULL
proteint	NULL
Oct2	NULL
mRNAt§	NULL
Oct2	NULL
BOB.1	NULL
mRNAt§	NULL
-	NULL
BOB.1	NULL
protein	NULL
'	NULL
]	NULL
-	NULL
+	NULL
+	NULL
+	NULL
+	NULL
1	NULL
1	NULL
tot	NULL
+	NULL
+	NULL
4+	NULL
+	NULL
+	NULL
mRNA	NULL
indicates	NULL
messenger	NULL
RNA	NULL
.	NULL

*B-JAB	NULL
,	NULL
Namalwa	NULL
,	NULL
Raji	NULL
,	NULL
Jok-1	NULL
,	NULL
and	NULL
DG-75	NULL
.	NULL

{	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

§Reverse	NULL
transcriptase-polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

[	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

immunohistochemistry	NULL
,	NULL
the	NULL
cell	NULL
lines	NULL
L428	NULL
and	NULL
KM-H2	NULL
derived	NULL
from	NULL
HRS	NULL
cells	NULL
of	NULL
cHD	NULL
cases	NULL
were	NULL
devoid	NULL
of	NULL
immunoglobulin-specific	NULL
transcripts	NULL
and	NULL
protein	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
of	NULL
all	NULL
but	NULL
2	NULL
cases	NULL
were	NULL
labeled	NULL
with	NULL
immunoglobulin-specific	NULL
probes	NULL
with	NULL
an	NULL
intensity	NULL
between	NULL
that	NULL
generally	NULL
seen	NULL
in	NULL
plasma	NULL
cells	NULL
and	NULL
B	NULL
lymphocytes	NULL
(	NULL
Table	NULL
1	NULL
,	NULL
Figure	NULL
1A	NULL
)	NULL
.	NULL

Immunostaining	NULL
with	NULL
antibodies	NULL
directed	NULL
at	NULL
immunoglobulin	NULL
isotypes	NULL
revealed	NULL
a	NULL
very	NULL
strong	NULL
labeling	NULL
of	NULL
the	NULL
nuclear	NULL
space	NULL
and	NULL
the	NULL
cytoplasm	NULL
of	NULL
the	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
in	NULL
26	NULL
of	NULL
32	NULL
cases	NULL
(	NULL
Figure	NULL
1B-D	NULL
,	NULL
F	NULL
;	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

The	NULL
tumor	NULL
cells	NULL
of	NULL
8	NULL
cases	NULL
of	NULL
follicular	NULL
lymphoma	NULL
studied	NULL
for	NULL
control	NULL
purposes	NULL
showed	NULL
positive	NULL
labeling	NULL
for	NULL
immunoglobulin	NULL
mRNA	NULL
and	NULL
immunoglobulin	NULL
protein	NULL
in	NULL
all	NULL
instances	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

The	NULL
positive	NULL
immunoglobulin	NULL
staining	NULL
included	NULL
the	NULL
nuclear	NULL
space	NULL
in	NULL
all	NULL
8	NULL
cases	NULL
.	NULL

The	NULL
frequency	NULL
with	NULL
which	NULL
the	NULL
different	NULL
IgH	NULL
classes	NULL
and	NULL
the	NULL
Cases	NULL
with	NULL
labeled	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
Immunoglobulin	NULL
No	NULL
.	NULL

cases	NULL
isotype	NULL
studied	NULL
mRNA	NULL
Protein	NULL
Ign	NULL
:	NULL
34	NULL
3	NULL
3	NULL
Igo	NULL
34	NULL
3	NULL
3	NULL
Igy	NULL
34	NULL
21	NULL
9	NULL
Ig	NULL
27	NULL
18	NULL
16	NULL
IgA	NULL
27	NULL
2	NULL
2	NULL
For	NULL
L	NULL
&	NULL
H	NULL
definition	NULL
,	NULL
see	NULL
Table	NULL
1	NULL
;	NULL
mRNA	NULL
,	NULL
messenger	NULL
RNA	NULL
;	NULL
Ig	NULL
,	NULL
immunoglobulin	NULL
.	NULL

IgL	NULL
types	NULL
were	NULL
found	NULL
to	NULL
be	NULL
expressed	NULL
by	NULL
the	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
is	NULL
shown	NULL
in	NULL
Table	NULL
3	NULL
.	NULL

Expression	NULL
of	NULL
BOB.1/0BF.1	NULL
and	NULL
Oct2	NULL
in	NULL
cHD	NULL
and	NULL
LPHD	NULL
The	NULL
expression	NULL
of	NULL
BOB.1/0BF.1	NULL
and	NULL
Oct2	NULL
was	NULL
studied	NULL
by	NULL
immunohistochemistry	NULL
.	NULL

BOB.1/0BF.1	NULL
and	NULL
Oct2	NULL
were	NULL
completely	NULL
absent	NULL
from	NULL
the	NULL
HRS	NULL
cells	NULL
of	NULL
24	NULL
(	NULL
75	NULL
%	NULL
)	NULL
and	NULL
28	NULL
(	NULL
87.5	NULL
%	NULL
)	NULL
of	NULL
the	NULL
32	NULL
cHD	NULL
cases	NULL
,	NULL
respectively	NULL
(	NULL
Table	NULL
1	NULL
;	NULL
Figure	NULL
2B	NULL
,	NULL
D	NULL
)	NULL
.	NULL

In	NULL
the	NULL
remaining	NULL
cases	NULL
only	NULL
a	NULL
small	NULL
proportion	NULL
of	NULL
the	NULL
HRS	NULL
cells	NULL
showed	NULL
a	NULL
weak	NULL
labeling	NULL
for	NULL
these	NULL
proteins	NULL
(	NULL
Figure	NULL
2C	NULL
)	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
one	NULL
case	NULL
in	NULL
which	NULL
all	NULL
HRS	NULL
cells	NULL
showed	NULL
a	NULL
strong	NULL
labeling	NULL
for	NULL
Oct2	NULL
protein	NULL
.	NULL

To	NULL
check	NULL
the	NULL
validity	NULL
of	NULL
the	NULL
negative	NULL
labeling	NULL
for	NULL
Oct2	NULL
in	NULL
HRS	NULL
cells	NULL
,	NULL
11	NULL
cases	NULL
were	NULL
examined	NULL
by	NULL
in	NULL
situ	NULL
hybridization	NULL
with	NULL
a	NULL
radioactive	NULL
Oct2	NULL
probe	NULL
.	NULL

In	NULL
9	NULL
cases	NULL
there	NULL
were	NULL
no	NULL
signals	NULL
over	NULL
the	NULL
HRS	NULL
cells	NULL
,	NULL
although	NULL
internal	NULL
control	NULL
cells	NULL
were	NULL
labeled	NULL
(	NULL
Table	NULL
1	NULL
,	NULL
Figure	NULL
2A	NULL
)	NULL
.	NULL

In	NULL
difference	NULL
to	NULL
cHD	NULL
,	NULL
expression	NULL
of	NULL
BOB.1/OBF.1	NULL
and	NULL
Oct2	NULL
was	NULL
demonstrable	NULL
in	NULL
all	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
of	NULL
all	NULL
LPHD	NULL
cases	NULL
studied	NULL
(	NULL
Table	NULL
1	NULL
,	NULL
Figure	NULL
3A	NULL
)	NULL
.	NULL

The	NULL
immunostaining	NULL
of	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
for	NULL
BOB.1/0BF.1	NULL
was	NULL
as	NULL
strong	NULL
as	NULL
in	NULL
normal	NULL
and	NULL
neoplastic	NULL
germinal	NULL
center	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
the	NULL
labeling	NULL
for	NULL
Oct2	NULL
proved	NULL
to	NULL
be	NULL
much	NULL
more	NULL
intense	NULL
in	NULL
y	NULL
``	NULL
``	NULL
Figure	NULL
1	NULL
.	NULL

Lymphocyte	NULL
predominant	NULL
Hodgkin	NULL
disease	NULL
.	NULL

(	NULL
A	NULL
,	NULL
E	NULL
)	NULL
Radioactive	NULL
in	NULL
situ	NULL
hybridization	NULL
with	NULL
probes	NULL
spe-3	NULL
-	NULL
cific	NULL
for	NULL
Igy	NULL
and	NULL
mRNA	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
(	NULL
white	NULL
arrows	NULL
)	NULL
are	NULL
positive	NULL
with	NULL
an	NULL
intensity	NULL
between	NULL
that	NULL
seen	NULL
in	NULL
plasma	NULL
cells	NULL
and	NULL
B	NULL
cells	NULL
(	NULL
black	NULL
arrows	NULL
)	NULL
.	NULL

(	NULL
B-D	NULL
,	NULL
F	NULL
)	NULL
Immunostaining	NULL
for	NULL
Igy	NULL
,	NULL
-m	NULL
,	NULL
-8	NULL
,	NULL
and	NULL
-A	NULL
,	NULL
using	NULL
a	NULL
avidin-bictin-peroxidase	NULL
method	NULL
.	NULL

The	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
display	NULL
a	NULL
strong	NULL
labeling	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

BLOOD	NULL
,	NULL
15	NULL
JANUARY	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
2	NULL
Figure	NULL
2	NULL
.	NULL

Classical	NULL
Hodgkin	NULL
disease	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Radioactive	NULL
in	NULL
situ	NULL
hybridization	NULL
with	NULL
a	NULL
probe	NULL
specific	NULL
for	NULL
Oct2	NULL
mRNA	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
bystander	NULL
B	NULL
cells	NULL
,	NULL
HRS	NULL
cells	NULL
remained	NULL
completely	NULL
unlabeled	NULL
(	NULL
arrows	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Immunostaining	NULL
for	NULL
Oct2	NULL
.	NULL

All	NULL
HRS	NULL
cells	NULL
are	NULL
unlabeled	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Immunostaining	NULL
for	NULL
Oct2	NULL
.	NULL

A	NULL
proportion	NULL
of	NULL
HRS	NULL
cells	NULL
is	NULL
positive	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Immunostaining	NULL
for	NULL
BOB.1/OBE1	NULL
.	NULL

HRS	NULL
cells	NULL
are	NULL
negative	NULL
.	NULL

All	NULL
immunolabeling	NULL
reactions	NULL
were	NULL
performed	NULL
with	NULL
the	NULL
APAAP	NULL
technique	NULL
.	NULL

the	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
when	NULL
compared	NULL
with	NULL
normal	NULL
cells	NULL
and	NULL
the	NULL
tumor	NULL
cells	NULL
of	NULL
follicular	NULL
lymphoma	NULL
(	NULL
Figure	NULL
3A	NULL
,	NULL
B	NULL
)	NULL
.	NULL

Co-transfection	NULL
of	NULL
cultured	NULL
HRS	NULL
cells	NULL
with	NULL
immunoglobulin	NULL
promoter-reporter	NULL
constructs	NULL
and	NULL
Oct2	NULL
and/or	NULL
BOB.1/0BF.1	NULL
The	NULL
above	NULL
findings	NULL
prompted	NULL
the	NULL
question	NULL
as	NULL
to	NULL
whether	NULL
direct	NULL
evidence	NULL
can	NULL
be	NULL
provided	NULL
showing	NULL
that	NULL
the	NULL
lack	NULL
of	NULL
the	NULL
Oct2	NULL
transcription	NULL
factor	NULL
and	NULL
the	NULL
BOB.1/0BE.1	NULL
coactivator	NULL
is	NULL
decisive	NULL
for	NULL
deficient	NULL
immunoglobulin	NULL
gene	NULL
transcription	NULL
in	NULL
HRS	NULL
cells	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
we	NULL
cotransfected	NULL
the	NULL
HD-derived	NULL
cell	NULL
line	NULL
L428	NULL
with	NULL
wild-type	NULL
and	NULL
mutated	NULL
(	NULL
point	NULL
mutation	NULL
in	NULL
the	NULL
promoter	NULL
octamer	NULL
motif	NULL
)	NULL
immunoglobulin	NULL
reporter	NULL
constructs	NULL
either	NULL
with	NULL
BOB.1/	NULL
OBF.1	NULL
or	NULL
Oct2	NULL
expression	NULL
vectors	NULL
individually	NULL
or	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
both	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
4A	NULL
,	NULL
the	NULL
wild-type	NULL
immunoglobulin	NULL
reporter	NULL
was	NULL
slightly	NULL
stimulated	NULL
by	NULL
BOB.1/0BE.1	NULL
and	NULL
to	NULL
a	NULL
lower	NULL
extent	NULL
induced	NULL
by	NULL
Oct2	NULL
.	NULL

The	NULL
combination	NULL
of	NULL
both	NULL
factors	NULL
,	NULL
however	NULL
,	NULL
resulted	NULL
in	NULL
a	NULL
significantly	NULL
higher	NULL
stimulation	NULL
of	NULL
immunoglobulin	NULL
reporter	NULL
gene	NULL
activity	NULL
.	NULL

This	NULL
activity	NULL
was	NULL
virtually	NULL
identical	NULL
to	NULL
that	NULL
obtained	NULL
in	NULL
a	NULL
normal	NULL
B-cell	NULL
line	NULL
expressing	NULL
endogenous	NULL
levels	NULL
of	NULL
these	NULL
factors	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
were	NULL
confirmed	NULL
by	NULL
transfection	NULL
of	NULL
L428	NULL
with	NULL
immunoglobulin	NULL
reporter	NULL
constructs	NULL
that	NULL
contain	NULL
multimerized	NULL
``	NULL
L	NULL
12	NULL
00	NULL
Ne	NULL
x-	NULL
«	NULL
ri	NULL
?	NULL

ét~riﬁ	NULL
Figure	NULL
3	NULL
.	NULL

Lymphocyte	NULL
predominant	NULL
Hodgkin	NULL
disease	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Radioactive	NULL
in	NULL
situ	NULL
hybridization	NULL
with	NULL
a	NULL
probe	NULL
specific	NULL
for	NULL
Oct2	NULL
.	NULL

L	NULL
&	NULL
H	NULL
cells	NULL
show	NULL
dense	NULL
signals	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Immunostaining	NULL
(	NULL
APAAP	NULL
)	NULL
for	NULL
Oct2	NULL
.	NULL

The	NULL
nuclei	NULL
of	NULL
the	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
are	NULL
strongly	NULL
labeled	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Immunostaining	NULL
(	NULL
APAAP	NULL
)	NULL
for	NULL
BOB.1/OBF.1	NULL
.	NULL

The	NULL
nuclei	NULL
and	NULL
the	NULL
cytoplasma	NULL
(	NULL
less	NULL
intense	NULL
)	NULL
of	NULL
the	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
display	NULL
a	NULL
moderately	NULL
strong	NULL
labeling	NULL
.	NULL

TRANSCRIPTION	NULL
FACTORS	NULL
IN	NULL
HODGKIN	NULL
DISEASE	NULL
-	NULL
499	NULL
A25	NULL
B40	NULL
20	NULL
&	NULL
&	NULL
3	NULL
3	NULL
B	NULL
E	NULL
£	NULL
``	NULL
a	NULL
``	NULL
a	NULL
s	NULL
s	NULL
2	NULL
Eu	NULL
,	NULL
5	NULL
0	NULL
0	NULL
104	NULL
00	NULL
%	NULL
-	NULL
+	NULL
-	NULL
+	NULL
10	NULL
%	NULL
0	NULL
%	NULL
-	NULL
+	NULL
-	NULL
+	NULL
BOB./OBEI	NULL
-	NULL
+	NULL
+	NULL
<	NULL
0	NULL
.	NULL

+	NULL
+	NULL
Oc	NULL
?	NULL

6000+	NULL
+	NULL
-	NULL
+	NULL
+/	NULL
Ocf	NULL
?	NULL

ETLIne	NULL
ETImlue	NULL
4x	NULL
wt	NULL
4x	NULL
mut	NULL
C	NULL
uETiive	NULL
uETim.ue	NULL
4x	NULL
wt	NULL
4	NULL
x	NULL
mut	NULL
W	NULL
Figure	NULL
4	NULL
.	NULL

Transient	NULL
cotransfections	NULL
of	NULL
HD-derived	NULL
L428	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
L428	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
immunoglobulin	NULL
promoter/enhancer-driven	NULL
luciferase	NULL
reporters	NULL
and	NULL
expression	NULL
vectors	NULL
for	NULL
BOB.1/OBE1	NULL
and/or	NULL
Oct2	NULL
as	NULL
indicated	NULL
.	NULL

mET1.luc	NULL
represents	NULL
reporter	NULL
wild	NULL
type	NULL
promoter	NULL
element	NULL
extending	NULL
from	NULL
+19	NULL
to	NULL
-131	NULL
,	NULL
wEtm.luc	NULL
contains	NULL
the	NULL
same	NULL
promoter	NULL
element	NULL
with	NULL
point	NULL
mutations	NULL
in	NULL
the	NULL
octamer	NULL
mofif	NULL
(	NULL
see	NULL
C	NULL
)	NULL
.	NULL

Relative	NULL
activity	NULL
is	NULL
shown	NULL
and	NULL
the	NULL
cotransfections	NULL
with	NULL
empty	NULL
expression	NULL
vectors	NULL
were	NULL
arbitrarily	NULL
set	NULL
to	NULL
1	NULL
.	NULL

(	NULL
B	NULL
)	NULL
L428	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
wild	NULL
type	NULL
(	NULL
4	NULL
X	NULL
wt	NULL
)	NULL
or	NULL
mutant	NULL
(	NULL
4	NULL
X	NULL
mut	NULL
)	NULL
octamer-dependent	NULL
luciferase	NULL
reporters	NULL
together	NULL
with	NULL
expression	NULL
vectors	NULL
for	NULL
BOB.1/OBF.1	NULL
and/or	NULL
Oct2	NULL
as	NULL
indicated	NULL
.	NULL

Relative	NULL
activity	NULL
is	NULL
shown	NULL
and	NULL
the	NULL
cotransfections	NULL
with	NULL
empty	NULL
expression	NULL
vectors	NULL
were	NULL
arbitrarily	NULL
set	NULL
to	NULL
1	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Schematic	NULL
representation	NULL
of	NULL
the	NULL
reporter	NULL
constructs	NULL
used	NULL
in	NULL
A	NULL
and	NULL
B.	NULL
Wild-type	NULL
octamer	NULL
motifs	NULL
in	NULL
the	NULL
immunoglobulin	NULL
promoter	NULL
or	NULL
synthetic	NULL
promoter	NULL
are	NULL
indicated	NULL
as	NULL
filled	NULL
circles	NULL
;	NULL
mutant	NULL
octamer	NULL
motifs	NULL
are	NULL
shown	NULL
as	NULL
open	NULL
circles	NULL
.	NULL

Details	NULL
about	NULL
the	NULL
reporter	NULL
constructs	NULL
can	NULL
be	NULL
found	NULL
in	NULL
Laumen	NULL
et	NULL
al	NULL
'	NULL
?	NULL

(	NULL
for	NULL
ETA	NULL
.Juc	NULL
and	NULL
ETim.luc	NULL
)	NULL
or	NULL
Pfisterer	NULL
et	NULL
al	NULL
'	NULL
``	NULL
(	NULL
for	NULL
4	NULL
X	NULL
wt	NULL
and	NULL
4	NULL
X	NULL
mut	NULL
)	NULL
.	NULL

octamer	NULL
motifs	NULL
upstream	NULL
of	NULL
a	NULL
minimal	NULL
promoter	NULL
consisting	NULL
of	NULL
only	NULL
a	NULL
TATA	NULL
box	NULL
(	NULL
Figure	NULL
4B	NULL
)	NULL
.	NULL

Transfection	NULL
of	NULL
the	NULL
multimerized	NULL
immunoglobulin	NULL
reporter	NULL
construct	NULL
with	NULL
BOB.1/0BF.1	NULL
resulted	NULL
in	NULL
a	NULL
strong	NULL
stimulation	NULL
of	NULL
wild-type	NULL
octamer	NULL
promoter	NULL
activity	NULL
,	NULL
whereas	NULL
transfection	NULL
with	NULL
Oct2	NULL
displayed	NULL
only	NULL
a	NULL
marginal	NULL
effect	NULL
on	NULL
immunoglobulin	NULL
reporter	NULL
activity	NULL
.	NULL

The	NULL
BOB.1/0BF.1-induced	NULL
immunoglobulin	NULL
promoter	NULL
activity	NULL
could	NULL
be	NULL
increased	NULL
further	NULL
by	NULL
cotransfection	NULL
of	NULL
BOB.1/0BF.1	NULL
together	NULL
with	NULL
Oct2	NULL
(	NULL
Figure	NULL
4B	NULL
)	NULL
.	NULL

Mutated	NULL
multimerized	NULL
immunoglobulin	NULL
reporter	NULL
constructs	NULL
showed	NULL
no	NULL
significant	NULL
activity	NULL
under	NULL
all	NULL
conditions	NULL
tested	NULL
(	NULL
Figure	NULL
4B	NULL
)	NULL
.	NULL

Discussion	NULL
In	NULL
this	NULL
study	NULL
we	NULL
have	NULL
analyzed	NULL
how	NULL
consistent	NULL
cHD	NULL
and	NULL
LPHD	NULL
differ	NULL
from	NULL
each	NULL
other	NULL
in	NULL
their	NULL
expression	NULL
of	NULL
immunoglobulin	NULL
and	NULL
which	NULL
molecular	NULL
mechanisms	NULL
might	NULL
account	NULL
for	NULL
this	NULL
difference	NULL
.	NULL

We	NULL
have	NULL
confirmed	NULL
our	NULL
previous	NULL
findings	NULL
that	NULL
HRS	NULL
cells	NULL
of	NULL
all	NULL
(	NULL
or	NULL
nearly	NULL
all	NULL
)	NULL
cases	NULL
of	NULL
cHD	NULL
lack	NULL
transcripts	NULL
specific	NULL
for	NULL
IgL	NULL
and	NULL
IgH	NULL
chains	NULL
``	NULL
and	NULL
have	NULL
found	NULL
that	NULL
the	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
of	NULL
LPHD	NULL
overexpress	NULL
immunoglobulin	NULL
at	NULL
the	NULL
protein	NULL
and/or	NULL
transcriptional	NULL
level	NULL
in	NULL
most	NULL
instances	NULL
when	NULL
compared	NULL
with	NULL
normal	NULL
follicular	NULL
mantle	NULL
cells	NULL
and	NULL
follicular	NULL
lymphoma	NULL
cells	NULL
.	NULL

We	NULL
have	NULL
in	NULL
addition	NULL
found	NULL
that	NULL
the	NULL
octamer	NULL
transcription	NULL
factor	NULL
Oct2	NULL
is	NULL
highly	NULL
overexpressed	NULL
in	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
but	NULL
totally	NULL
absent	NULL
from	NULL
87.5	NULL
%	NULL
of	NULL
the	NULL
cases	NULL
or	NULL
only	NULL
partially	NULL
(	NULL
9.4	NULL
%	NULL
)	NULL
present	NULL
in	NULL
classical	NULL
HRS	NULL
cells	NULL
.	NULL

There	NULL
was	NULL
only	NULL
one	NULL
exception	NULL
to	NULL
this	NULL
in	NULL
which	NULL
all	NULL
HRS	NULL
cells	NULL
expressed	NULL
Oct2	NULL
at	NULL
a	NULL
relatively	NULL
high	NULL
level	NULL
.	NULL

BOB.1/0BE.1	NULL
,	NULL
the	NULL
coactivator	NULL
of	NULL
Oct2	NULL
,	NULL
proved	NULL
to	NULL
be	NULL
consistently	NULL
expressed	NULL
in	NULL
the	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
at	NULL
a	NULL
level	NULL
equivalent	NULL
to	NULL
that	NULL
seen	NULL
in	NULL
reactive	NULL
and	NULL
neoplastic	NULL
germinal	NULL
center	NULL
B	NULL
cells	NULL
,	NULL
whereas	NULL
there	NULL
was	NULL
no	NULL
(	NULL
75	NULL
%	NULL
of	NULL
the	NULL
cases	NULL
)	NULL
or	NULL
only	NULL
very	NULL
little	NULL
expression	NULL
(	NULL
25	NULL
%	NULL
)	NULL
of	NULL
BOB.1/O0BF.1	NULL
in	NULL
classical	NULL
HRS	NULL
cells	NULL
.	NULL

Cotransfection	NULL
experiments	NULL
performed	NULL
revealed	NULL
that	NULL
the	NULL
reintroduction	NULL
of	NULL
BOB.1/0BF.1	NULL
and	NULL
Oct2	NULL
into	NULL
cultured	NULL
HRS	NULL
cells	NULL
can	NULL
restore	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

500	NULL
_	NULL
STEIN	NULL
etal	NULL
the	NULL
transcription	NULL
activity	NULL
of	NULL
the	NULL
immunoglobulin	NULL
promoter	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
these	NULL
findings	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
the	NULL
difference	NULL
in	NULL
the	NULL
immunoglobulin	NULL
expression	NULL
between	NULL
LPHD	NULL
and	NULL
cHD	NULL
does	NULL
not	NULL
lie	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
crippling	NULL
immunoglobulin	NULL
gene	NULL
mutations	NULL
in	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
and	NULL
their	NULL
presence	NULL
in	NULL
HRS	NULL
cells-as	NULL
recently	NULL
assumed-but	NULL
in	NULL
a	NULL
differing	NULL
expression	NULL
of	NULL
the	NULL
octamer	NULL
transcription	NULL
factor	NULL
Oct2	NULL
and/or	NULL
its	NULL
coactivator	NULL
BOB.1/0BE.1	NULL
.	NULL

In	NULL
the	NULL
past	NULL
,	NULL
many	NULL
studies*	NULL
``	NULL
``	NULL
``	NULL
have	NULL
been	NULL
performed	NULL
to	NULL
analyze	NULL
the	NULL
immunoglobulin	NULL
production	NULL
by	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
and	NULL
HRS	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
in	NULL
none	NULL
of	NULL
these	NULL
previous	NULL
studies	NULL
has	NULL
a	NULL
larger	NULL
series	NULL
of	NULL
cases	NULL
of	NULL
LPHD	NULL
and	NULL
cHD	NULL
been	NULL
investigated	NULL
in	NULL
parallel	NULL
with	NULL
a	NULL
highly	NULL
efficient	NULL
antigen	NULL
retrieval	NULL
procedure	NULL
and	NULL
a	NULL
highly	NULL
sensitive	NULL
radioactive	NULL
in	NULL
situ	NULL
hybridization	NULL
method	NULL
.	NULL

Furthermore	NULL
,	NULL
all	NULL
previous	NULL
in	NULL
situ	NULL
hybridization	NULL
studies	NULL
that	NULL
were	NULL
applied	NULL
to	NULL
LPHD	NULL
cases	NULL
were	NULL
restricted	NULL
to	NULL
IgL	NULL
chains	NULL
.	NULL

>	NULL
``	NULL
*	NULL
``	NULL
``	NULL
To	NULL
clarify	NULL
how	NULL
frequently	NULL
and	NULL
at	NULL
which	NULL
level	NULL
the	NULL
immunoglobulin	NULL
synthesis	NULL
in	NULL
the	NULL
tumor	NULL
cells	NULL
of	NULL
cHD	NULL
is	NULL
disturbed	NULL
,	NULL
it	NULL
is	NULL
necessary	NULL
to	NULL
obtain	NULL
representative	NULL
results	NULL
to	NULL
investigate	NULL
the	NULL
same	NULL
collection	NULL
of	NULL
cases	NULL
not	NULL
only	NULL
for	NULL
the	NULL
immunoglobulin	NULL
light	NULL
chain	NULL
types	NULL
x	NULL
and	NULL
A	NULL
but	NULL
also	NULL
for	NULL
the	NULL
heavy	NULL
chain	NULL
isotypes	NULL
Ign	NULL
,	NULL
Ig8	NULL
,	NULL
and	NULL
Igy	NULL
at	NULL
the	NULL
protein	NULL
and	NULL
RNA	NULL
levels	NULL
.	NULL

Another	NULL
important	NULL
reason	NULL
for	NULL
studying	NULL
cases	NULL
of	NULL
cHD	NULL
for	NULL
both	NULL
immunoglobulin	NULL
proteins	NULL
and	NULL
immunoglobulin	NULL
transcripts	NULL
in	NULL
parallel	NULL
lies	NULL
in	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
immunostaining	NULL
of	NULL
paraffin	NULL
sections	NULL
for	NULL
immunoglobulin	NULL
protein	NULL
often	NULL
leads-due	NULL
to	NULL
uptake	NULL
of	NULL
immunoglobulin	NULL
from	NULL
interstitial	NULL
fluids-to	NULL
a	NULL
falsely	NULL
positive	NULL
labeling	NULL
of	NULL
larger	NULL
cells	NULL
.	NULL

>	NULL
>	NULL
*25	NULL
The	NULL
tumor	NULL
cells	NULL
of	NULL
cHD	NULL
are	NULL
particularly	NULL
susceptible	NULL
to	NULL
immunoglobulin	NULL
uptake	NULL
during	NULL
the	NULL
formol	NULL
fixation	NULL
process	NULL
.	NULL
``	NULL

Falsely	NULL
positive	NULL
labeling	NULL
for	NULL
immunoglobulin	NULL
transcripts	NULL
due	NULL
to	NULL
uptake	NULL
does	NULL
not	NULL
occur	NULL
because	NULL
immunoglobulin	NULL
mRNA-in	NULL
difference	NULL
to	NULL
immunoglobulin	NULL
proteins-is	NULL
not	NULL
secreted	NULL
and	NULL
thus	NULL
is	NULL
not	NULL
present	NULL
in	NULL
the	NULL
extracellular	NULL
fluid	NULL
.	NULL

Because	NULL
of	NULL
these	NULL
reasons	NULL
and	NULL
to	NULL
establish	NULL
criteria	NULL
by	NULL
which	NULL
endogenous	NULL
immunoglobulin	NULL
protein	NULL
can	NULL
be	NULL
distinguished	NULL
from	NULL
uptaken	NULL
immunoglobulin	NULL
in	NULL
immunostains	NULL
,	NULL
we	NULL
subjected	NULL
a	NULL
larger	NULL
series	NULL
of	NULL
cases	NULL
of	NULL
cHD	NULL
and	NULL
of	NULL
LPHD	NULL
to	NULL
immunohistological	NULL
staining	NULL
for	NULL
IgH	NULL
and	NULL
IgL	NULL
proteins	NULL
and	NULL
corresponding	NULL
transcripts	NULL
.	NULL

The	NULL
comparison	NULL
of	NULL
the	NULL
immunohistological	NULL
findings	NULL
with	NULL
those	NULL
obtained	NULL
by	NULL
in	NULL
situ	NULL
hybridization	NULL
showed	NULL
that	NULL
there	NULL
are	NULL
high	NULL
congruent	NULL
labeling	NULL
results	NULL
if	NULL
the	NULL
evaluation	NULL
of	NULL
the	NULL
immunoglobulin	NULL
protein	NULL
labeling	NULL
is	NULL
restricted	NULL
to	NULL
the	NULL
perinuclear	NULL
space	NULL
,	NULL
indicating	NULL
that	NULL
immunoglobulin	NULL
that	NULL
is	NULL
immunohistochemi-cally	NULL
demonstrated	NULL
in	NULL
the	NULL
nuclear	NULL
space	NULL
represents	NULL
endogenous	NULL
immunoglobulin	NULL
rather	NULL
than	NULL
uptaken	NULL
immunoglobulin	NULL
proteins	NULL
.	NULL

Classical	NULL
HRS	NULL
cells	NULL
did	NULL
not	NULL
usually	NULL
show	NULL
a	NULL
staining	NULL
of	NULL
the	NULL
nuclear	NULL
space	NULL
for	NULL
immunoglobulin	NULL
.	NULL

Significant	NULL
signals	NULL
for	NULL
IgH-	NULL
or	NULL
IgL-chain-specific	NULL
mRNA	NULL
were	NULL
not	NULL
obtained	NULL
in	NULL
any	NULL
case	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
there	NULL
was	NULL
a	NULL
positive	NULL
labeling	NULL
of	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
for	NULL
immunoglobulin	NULL
transcripts	NULL
and	NULL
proteins	NULL
in	NULL
most	NULL
cases	NULL
.	NULL

The	NULL
immunoglobulin	NULL
protein	NULL
labeling	NULL
was	NULL
usually	NULL
very	NULL
intense	NULL
and	NULL
in	NULL
density	NULL
comparable	NULL
to	NULL
that	NULL
seen	NULL
in	NULL
plasma	NULL
cells	NULL
.	NULL

The	NULL
labeling	NULL
included	NULL
the	NULL
perinuclear	NULL
space	NULL
in	NULL
all	NULL
instances	NULL
,	NULL
which	NULL
is	NULL
difficult	NULL
to	NULL
recognize	NULL
in	NULL
the	NULL
photographs	NULL
because	NULL
of	NULL
the	NULL
density	NULL
of	NULL
the	NULL
label	NULL
.	NULL

The	NULL
density	NULL
of	NULL
the	NULL
immunoglobulin	NULL
transcript	NULL
signals	NULL
was	NULL
stronger	NULL
than	NULL
that	NULL
of	NULL
normal	NULL
B	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
increased	NULL
immunoglobulin	NULL
transcription	NULL
contributes	NULL
to	NULL
the	NULL
overexpression	NULL
of	NULL
immunoglobulin	NULL
in	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
.	NULL

In	NULL
the	NULL
majority	NULL
of	NULL
the	NULL
cases	NULL
the	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
proved	NULL
to	NULL
be	NULL
derived	NULL
from	NULL
class-switched	NULL
germinal	NULL
center	NULL
B	NULL
cells	NULL
as	NULL
revealed	NULL
by	NULL
the	NULL
immunoglobulin	NULL
isotypes	NULL
expressed	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
other	NULL
reports	NULL
``	NULL
*	NULL
``	NULL
``	NULL
we	NULL
were	NULL
recently	NULL
able	NULL
to	NULL
demonstrate	NULL
that	NULL
in	NULL
most	NULL
instances	NULL
the	NULL
rearranged	NULL
immunoglobulin	NULL
genes	NULL
are	NULL
not	NULL
only	NULL
functional	NULL
in	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
but	NULL
also	NULL
in	NULL
classical	NULL
HRS	NULL
cells	NULL
,	NULL
prompting	NULL
the	NULL
conclusion	NULL
that	NULL
the	NULL
absent	NULL
expression	NULL
of	NULL
immunoglobulin	NULL
molecules	NULL
in	NULL
HRS	NULL
cells	NULL
is	NULL
not	NULL
caused	NULL
by	NULL
crippling	NULL
BLOOD	NULL
,	NULL
15	NULL
JANUARY	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
2	NULL
mutations	NULL
of	NULL
the	NULL
rearranged	NULL
immunoglobulin	NULL
genes	NULL
but	NULL
by	NULL
silencing	NULL
the	NULL
immunoglobulin	NULL
promoter	NULL
.	NULL
``	NULL

We	NULL
confirmed	NULL
the	NULL
lack	NULL
of	NULL
immunoglobulin	NULL
promoter	NULL
activity	NULL
in	NULL
HRS	NULL
cells	NULL
by	NULL
analyzing	NULL
the	NULL
HD	NULL
cell	NULL
lines	NULL
L428	NULL
and	NULL
KM-H2	NULL
in	NULL
transient	NULL
transfection	NULL
experi-ments	NULL
.	NULL

An	NULL
immunoglobulin	NULL
promoter/enhancer	NULL
reporter	NULL
construct	NULL
showed	NULL
virtually	NULL
no	NULL
activity	NULL
in	NULL
these	NULL
cells	NULL
in	NULL
contrast	NULL
to	NULL
control	NULL
B-cell	NULL
lines	NULL
.	NULL

We	NULL
hypothesized	NULL
that	NULL
the	NULL
loss	NULL
of	NULL
immunoglobulin	NULL
promoter	NULL
activity	NULL
in	NULL
the	NULL
HRS	NULL
cells	NULL
might	NULL
be	NULL
due	NULL
to	NULL
an	NULL
absence	NULL
of	NULL
Oct2	NULL
and/or	NULL
BOB.1/0BF.1	NULL
and	NULL
,	NULL
if	NULL
true	NULL
,	NULL
that	NULL
HRS	NULL
cells	NULL
should	NULL
not	NULL
only	NULL
differ	NULL
from	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
in	NULL
immunoglobulin	NULL
expression	NULL
but	NULL
also	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
Oct2	NULL
and/or	NULL
BOB.1/0BF.1	NULL
.	NULL

To	NULL
verify	NULL
this	NULL
hypothesis	NULL
we	NULL
investigated	NULL
a	NULL
larger	NULL
series	NULL
of	NULL
cHD	NULL
and	NULL
LPHD	NULL
cases	NULL
by	NULL
immunohistochemistry	NULL
for	NULL
Oct2	NULL
and	NULL
BOB.1/0BF.1	NULL
protein	NULL
expression	NULL
and	NULL
correlated	NULL
the	NULL
results	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
immunoglobulin	NULL
protein	NULL
and/or	NULL
transcripts	NULL
.	NULL

For	NULL
comparison	NULL
we	NULL
included	NULL
8	NULL
cases	NULL
of	NULL
follicular	NULL
lymphoma	NULL
with	NULL
monotypic	NULL
IgH	NULL
and	NULL
IgL	NULL
expression	NULL
and	NULL
3	NULL
non-neoplastic	NULL
tonsils	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Our	NULL
investigations	NULL
revealed	NULL
that	NULL
L	NULL
&	NULL
H	NULL
cells-like	NULL
follicular	NULL
lymphoma	NULL
cells	NULL
and	NULL
non-neoplastic	NULL
germinal	NULL
center	NULL
B	NULL
cells-consistently	NULL
express	NULL
Oct2	NULL
and	NULL
BOB.1/0BF.1	NULL
with	NULL
the	NULL
only	NULL
difference	NULL
that	NULL
Oct2	NULL
proved	NULL
to	NULL
be	NULL
highly	NULL
overexpressed	NULL
in	NULL
the	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
in	NULL
all	NULL
instances	NULL
.	NULL

This	NULL
makes	NULL
Oct2	NULL
the	NULL
most	NULL
valuable	NULL
marker	NULL
for	NULL
the	NULL
identification	NULL
of	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
,	NULL
HRS	NULL
cells	NULL
proved	NULL
to	NULL
be	NULL
devoid	NULL
of	NULL
both	NULL
Oct2	NULL
and	NULL
BOB.1/0BF.1	NULL
in	NULL
most	NULL
cases	NULL
.	NULL

In	NULL
the	NULL
few	NULL
cases	NULL
in	NULL
which	NULL
only	NULL
one	NULL
of	NULL
the	NULL
2	NULL
factors	NULL
was	NULL
missing	NULL
it	NULL
could	NULL
be	NULL
shown	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
demonstrable	NULL
factor	NULL
was	NULL
low	NULL
and	NULL
restricted	NULL
to	NULL
a	NULL
usually	NULL
small	NULL
proportion	NULL
of	NULL
HRS	NULL
cells	NULL
.	NULL

There	NULL
was	NULL
no	NULL
case	NULL
in	NULL
which	NULL
both	NULL
Oct2	NULL
and	NULL
BOB.1/0BF.1	NULL
were	NULL
simultaneously	NULL
expressed	NULL
in	NULL
the	NULL
HRS	NULL
cells	NULL
.	NULL

The	NULL
absence	NULL
of	NULL
the	NULL
Oct2	NULL
protein	NULL
from	NULL
classical	NULL
HRS	NULL
cells	NULL
came	NULL
as	NULL
a	NULL
surprise	NULL
because	NULL
in	NULL
one	NULL
study	NULL
``	NULL
``	NULL
its	NULL
constant	NULL
presence	NULL
in	NULL
primary	NULL
HRS	NULL
cells	NULL
and	NULL
HD	NULL
cell	NULL
lines	NULL
,	NULL
including	NULL
the	NULL
L428	NULL
and	NULL
the	NULL
KM-H2	NULL
lines	NULL
,	NULL
was	NULL
reported	NULL
.	NULL

This	NULL
discrepancy	NULL
prompted	NULL
us	NULL
to	NULL
examine	NULL
the	NULL
validity	NULL
of	NULL
our	NULL
immunohistological	NULL
results	NULL
by	NULL
investigating	NULL
11	NULL
cases	NULL
of	NULL
cHD	NULL
,	NULL
4	NULL
cases	NULL
of	NULL
follicular	NULL
lymphoma	NULL
,	NULL
and	NULL
3	NULL
hyperplastic	NULL
tonsils	NULL
for	NULL
Oct2	NULL
mRNA	NULL
with	NULL
our	NULL
very	NULL
sensitive	NULL
radioactive	NULL
in	NULL
situ	NULL
hybridization	NULL
procedure	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
,	NULL
follicular	NULL
lymphoma	NULL
cells	NULL
,	NULL
and	NULL
normal	NULL
germinal	NULL
center	NULL
B	NULL
cells	NULL
,	NULL
the	NULL
HRS	NULL
cells	NULL
consistently	NULL
failed	NULL
to	NULL
give	NULL
rise	NULL
to	NULL
any	NULL
Oct2-specific	NULL
transcript	NULL
signals	NULL
.	NULL

We	NULL
also	NULL
re-evaluated	NULL
Oct2	NULL
expression	NULL
in	NULL
the	NULL
HD-derived	NULL
cell	NULL
lines	NULL
L428	NULL
and	NULL
KM-H2	NULL
,	NULL
using	NULL
various	NULL
RNA	NULL
and	NULL
protein	NULL
detection	NULL
methods	NULL
.	NULL

We	NULL
were	NULL
unable	NULL
to	NULL
detect	NULL
any	NULL
Oct2-specific	NULL
signals	NULL
with	NULL
any	NULL
of	NULL
the	NULL
methods	NULL
employed	NULL
.	NULL

In	NULL
light	NULL
of	NULL
the	NULL
highly	NULL
positive	NULL
correlation	NULL
between	NULL
immunoglobulin	NULL
production	NULL
and	NULL
expression	NULL
of	NULL
Oct2	NULL
and	NULL
BOB.1/0BF.1	NULL
,	NULL
it	NULL
is	NULL
tempting	NULL
to	NULL
assume	NULL
that	NULL
the	NULL
absent	NULL
transcription	NULL
of	NULL
immunoglobulin	NULL
genes	NULL
in	NULL
HRS	NULL
cells	NULL
is	NULL
due	NULL
to	NULL
the	NULL
lack	NULL
of	NULL
Oct2	NULL
and/or	NULL
BOB.1/0BF.1	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

To	NULL
strengthen	NULL
or	NULL
dismiss	NULL
this	NULL
conclu-sion	NULL
,	NULL
we	NULL
performed	NULL
cotransfection	NULL
experiments	NULL
in	NULL
which	NULL
we	NULL
reintroduced	NULL
BOB.1/0BF.1	NULL
and/or	NULL
Oct2	NULL
into	NULL
cultured	NULL
HRS	NULL
cells	NULL
(	NULL
L428	NULL
)	NULL
in	NULL
association	NULL
with	NULL
immunoglobulin	NULL
promoter-reporter	NULL
constructs	NULL
.	NULL

The	NULL
results	NULL
obtained	NULL
demonstrate	NULL
that	NULL
the	NULL
lack	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
is	NULL
indeed	NULL
the	NULL
likely	NULL
cause	NULL
for	NULL
the	NULL
defective	NULL
immunoglobulin	NULL
gene	NULL
transcription	NULL
in	NULL
HRS	NULL
cells	NULL
.	NULL

The	NULL
strongest	NULL
effect	NULL
was	NULL
seen	NULL
when	NULL
both	NULL
the	NULL
BOB.1/0BF.1	NULL
coactivator	NULL
and	NULL
the	NULL
Oct2	NULL
transcription	NULL
factor	NULL
were	NULL
cotransduced	NULL
.	NULL

However	NULL
,	NULL
the	NULL
transfection	NULL
of	NULL
BOB.1/0BF.1	NULL
by	NULL
itself	NULL
also	NULL
showed	NULL
a	NULL
significant	NULL
effect	NULL
.	NULL

This	NULL
observation	NULL
is	NULL
consistent	NULL
with	NULL
previous	NULL
studies	NULL
demonstrating	NULL
that	NULL
BOB.1/0OBE.1	NULL
can	NULL
also	NULL
function	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Oct2	NULL
as	NULL
a	NULL
coactivator	NULL
because	NULL
the	NULL
function	NULL
of	NULL
Oct2	NULL
can	NULL
be	NULL
replaced	NULL
by	NULL
the	NULL
ubiquitous	NULL
Oct1	NULL
transcription	NULL
factor	NULL
and	NULL
vice	NULL
versa	NULL
.	NULL
'	NULL

''	NULL
In	NULL
line	NULL
with	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

BLOOD	NULL
,	NULL
15	NULL
JANUARY	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
2	NULL
this	NULL
assumption	NULL
,	NULL
Oct1	NULL
is	NULL
expressed	NULL
in	NULL
the	NULL
cultured	NULL
HRS	NULL
cells	NULL
used	NULL
for	NULL
our	NULL
transfection	NULL
experiments	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
the	NULL
effect	NULL
of	NULL
BOB.1/0BF.1	NULL
is	NULL
augmented	NULL
by	NULL
Oct2	NULL
in	NULL
the	NULL
cultured	NULL
HRS	NULL
cells	NULL
suggests	NULL
that	NULL
in	NULL
more	NULL
advanced	NULL
differentiated	NULL
B	NULL
cells-as	NULL
the	NULL
HRS	NULL
cells	NULL
are	NULL
``	NULL
``	NULL
>	NULL
``	NULL
>	NULL
-Octl	NULL
can	NULL
not	NULL
fully	NULL
replace	NULL
the	NULL
function	NULL
of	NULL
Oct2	NULL
.	NULL

This	NULL
conclusion	NULL
is	NULL
in	NULL
harmony	NULL
with	NULL
more	NULL
recent	NULL
work	NULL
showing	NULL
that	NULL
in	NULL
later-stage	NULL
B	NULL
cells	NULL
Oct2	NULL
is	NULL
more	NULL
important	NULL
for	NULL
immunoglobulin	NULL
transcription	NULL
than	NULL
Oct1	NULL
.	NULL

>	NULL
The	NULL
stronger	NULL
role	NULL
of	NULL
Oct2	NULL
in	NULL
later-stage	NULL
B	NULL
cells	NULL
might	NULL
also	NULL
explain	NULL
the	NULL
absence	NULL
of	NULL
immunoglobulin	NULL
transcription	NULL
in	NULL
the	NULL
few	NULL
cases	NULL
of	NULL
cHD	NULL
in	NULL
which	NULL
the	NULL
HRS	NULL
cells	NULL
were	NULL
negative	NULL
for	NULL
Oct2	NULL
but	NULL
partially	NULL
positive	NULL
for	NULL
BOB.1/OBF.1	NULL
.	NULL

We	NULL
,	NULL
therefore	NULL
,	NULL
speculate	NULL
that	NULL
the	NULL
down-regulated	NULL
expression	NULL
of	NULL
BOB.1/0BF.1	NULL
as	NULL
well	NULL
as	NULL
that	NULL
of	NULL
Oct2	NULL
are	NULL
both	NULL
critical	NULL
events	NULL
for	NULL
the	NULL
loss	NULL
of	NULL
immunoglobulin	NULL
transcription	NULL
through	NULL
HRS	NULL
cells	NULL
.	NULL

Because	NULL
the	NULL
strong	NULL
overexpression	NULL
of	NULL
Oct2	NULL
correlates	NULL
to	NULL
the	NULL
TRANSCRIPTION	NULL
FACTORS	NULL
IN	NULL
HODGKIN	NULL
DISEASE	NULL
_	NULL
501	NULL
high	NULL
level	NULL
of	NULL
immunoglobulin	NULL
in	NULL
LPHD	NULL
in	NULL
the	NULL
majority	NULL
of	NULL
cases	NULL
,	NULL
it	NULL
is	NULL
suggestive	NULL
that	NULL
the	NULL
enormous	NULL
amount	NULL
of	NULL
Oct2	NULL
in	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
might	NULL
be	NULL
responsible	NULL
for	NULL
,	NULL
or	NULL
contribute	NULL
to	NULL
,	NULL
the	NULL
frequent	NULL
overexpression	NULL
of	NULL
immunoglobulin	NULL
by	NULL
these	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
what	NULL
is	NULL
more	NULL
difficult	NULL
to	NULL
understand	NULL
are	NULL
the	NULL
2	NULL
cases	NULL
of	NULL
LPHD	NULL
in	NULL
which	NULL
Oct2	NULL
is	NULL
overexpressed	NULL
and	NULL
BOB.1/0BF.1	NULL
is	NULL
normally	NULL
expressed	NULL
,	NULL
but	NULL
no	NULL
immunoglobulin	NULL
production	NULL
is	NULL
detectable	NULL
.	NULL

This	NULL
points	NULL
to	NULL
the	NULL
possibility	NULL
that	NULL
a	NULL
further	NULL
as	NULL
yet	NULL
unidentified	NULL
factor	NULL
(	NULL
or	NULL
factors	NULL
)	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
immunoglobulin	NULL
expression	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
H.	NULL
Protz	NULL
,	NULL
A.	NULL
Foerster	NULL
,	NULL
E.	NULL
Berg	NULL
,	NULL
E.	NULL
Seibt	NULL
,	NULL
and	NULL
L.	NULL
Ochring	NULL
for	NULL
their	NULL
excellent	NULL
technical	NULL
assistance	NULL
as	NULL
well	NULL
as	NULL
L.	NULL
Udvarhelyi	NULL
for	NULL
his	NULL
help	NULL
with	NULL
the	NULL
preparation	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Stein	NULL
H	NULL
,	NULL
Hummel	NULL
M	NULL
,	NULL
Diirkop	NULL
H	NULL
,	NULL
Foss	NULL
HD	NULL
,	NULL
Herbst	NULL
11	NULL
.	NULL

Sauter	NULL
P	NULL
,	NULL
Matthias	NULL
P.	NULL
Coactivator	NULL
OBF-1	NULL
makes	NULL
22	NULL
.	NULL

Taylor	NULL
CR	NULL
.	NULL

The	NULL
nature	NULL
of	NULL
Reed-Stemberg	NULL
cells	NULL
H.	NULL
Biology	NULL
of	NULL
Hodgkin	NULL
's	NULL
disease	NULL
.	NULL

In	NULL
:	NULL
Canellos	NULL
GP	NULL
,	NULL
selective	NULL
contacts	NULL
with	NULL
both	NULL
the	NULL
POU-specific	NULL
do-	NULL
and	NULL
other	NULL
malignant	NULL
``	NULL
reticulum	NULL
``	NULL
cells	NULL
.	NULL

Lancet	NULL
.	NULL

Lister	NULL
TA	NULL
,	NULL
Sklar	NULL
J	NULL
,	NULL
eds	NULL
.	NULL

The	NULL
Lymphomas	NULL
.	NULL

Phila-	NULL
main	NULL
and	NULL
the	NULL
POU	NULL
homeodomain	NULL
and	NULL
acts	NULL
as	NULL
a	NULL
1974	NULL
;	NULL
2:802-807.	NULL
delphia	NULL
,	NULL
PA	NULL
:	NULL
WB	NULL
Saunders	NULL
;	NULL
1998:287.	NULL
molecular	NULL
clamp	NULL
on	NULL
DNA	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
.	NULL

1998	NULL
;	NULL
18	NULL
:	NULL
23	NULL
.	NULL

Taylor	NULL
CR	NULL
.	NULL

An	NULL
immunchistological	NULL
study	NULL
of	NULL
follicu-2	NULL
.	NULL

Anagnostopoulos	NULL
I	NULL
,	NULL
Hansmann	NULL
ML	NULL
,	NULL
Franssila	NULL
K	NULL
,	NULL
7397-7409.	NULL
lar	NULL
lymphoma	NULL
,	NULL
reticulum	NULL
cell	NULL
sarcoma	NULL
and	NULL
et	NULL
al	NULL
.	NULL

European	NULL
task	NULL
force	NULL
on	NULL
lymphoma	NULL
project	NULL
12	NULL
.	NULL

Laumen	NULL
H	NULL
,	NULL
Nielsen	NULL
PJ	NULL
,	NULL
Wirth	NULL
T.	NULL
The	NULL
BOB.1/	NULL
Hodgkin	NULL
's	NULL
disease	NULL
.	NULL

Eur	NULL
J	NULL
Cancer	NULL
.	NULL

1976	NULL
;	NULL
12:61-75.	NULL
on	NULL
lymphocyte	NULL
predominance	NULL
Hodgkin	NULL
disease	NULL
:	NULL
OBF.1	NULL
coactivator	NULL
is	NULL
essential	NULL
for	NULL
octamer-depen-	NULL
__	NULL
24	NULL
.	NULL

Mason	NULL
DY	NULL
,	NULL
Stein	NULL
H	NULL
,	NULL
Naiem	NULL
M	NULL
,	NULL
Abdulaziz	NULL
Z.	NULL
Immu-histological	NULL
and	NULL
immunchistological	NULL
analysis	NULL
of	NULL
dent	NULL
transcription	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
.	NULL

2000	NULL
;	NULL
nohistological	NULL
analysis	NULL
of	NULL
human	NULL
lymphoid	NULL
tissue	NULL
submitted	NULL
cases	NULL
reveals	NULL
two	NULL
types	NULL
of	NULL
Hodgkin	NULL
30:458-469.	NULL
by	NULL
double	NULL
immuncenzymatic	NULL
labelling	NULL
.	NULL

J	NULL
Cancer	NULL
d|sIease	NULL
with	NULL
abundant	NULL
lymphocytes	NULL
.	NULL

Blood	NULL
.	NULL

2000	NULL
;	NULL
13	NULL
.	NULL

Stein	NULL
H	NULL
,	NULL
Diehl	NULL
V	NULL
,	NULL
Marafioti	NULL
T	NULL
,	NULL
Jox	NULL
A	NULL
,	NULL
Wolf	NULL
J	NULL
,	NULL
Hum-	NULL
Res	NULL
.	NULL

Clin	NULL
Oncol	NULL
.	NULL

1981	NULL
;	NULL
101:13-22	NULL
.	NULL

L	NULL
,	NULL
96:1889-1899.	NULL
mel	NULL
M.	NULL
The	NULL
nature	NULL
of	NULL
Reed-Sternberg	NULL
cells	NULL
,	NULL
lym-	NULL
25	NULL
.	NULL

Stein	NULL
H	NULL
,	NULL
Gerdes	NULL
J	NULL
,	NULL
Schwab	NULL
U	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Identification	NULL
3	NULL
.	NULL

Marafioti	NULL
T	NULL
,	NULL
Hummel	NULL
!	NULL

M	NULL
,	NULL
Anagnostopoulos	NULL
I	NULL
,	NULL
et	NULL
al	NULL
.	NULL

phocytic	NULL
and	NULL
histiocytic	NULL
cells	NULL
and	NULL
their	NULL
molecular	NULL
of	NULL
Hodgkin	NULL
and	NULL
Sternberg-Reed	NULL
cells	NULL
as	NULL
a	NULL
unique	NULL
Origin	NULL
of	NULL
nodular	NULL
Iymphocyte-predominant	NULL
biology	NULL
in	NULL
Hodgkin	NULL
's	NULL
disease	NULL
.	NULL

In	NULL
:	NULL
Mauch	NULL
P	NULL
,	NULL
Armit-	NULL
cell	NULL
type	NULL
derived	NULL
from	NULL
a	NULL
newly-detected	NULL
small-cell	NULL
Hodgkin	NULL
's	NULL
disease	NULL
from	NULL
a	NULL
clonal	NULL
expansion	NULL
of	NULL
age	NULL
J	NULL
,	NULL
Diehl	NULL
!	NULL

V	NULL
,	NULL
Hoppe	NULL
R	NULL
,	NULL
Weiss	NULL
LM	NULL
,	NULL
eds	NULL
.	NULL

population	NULL
.	NULL

Int	NULL
J	NULL
Cancer	NULL
.	NULL

1982	NULL
;	NULL
30:445-459.	NULL
highly	NULL
mutated	NULL
germinal-center	NULL
B	NULL
cells	NULL
[	NULL
see	NULL
com-	NULL
Hodgkin	NULL
's	NULL
Disease	NULL
.	NULL

Philadelphia	NULL
,	NULL
PA	NULL
:	NULL
Lippincott	NULL
26	NULL
.	NULL

Ruprai	NULL
AK	NULL
,	NULL
Pringle	NULL
JH	NULL
,	NULL
Angel	NULL
CA	NULL
,	NULL
Kind	NULL
CN	NULL
,	NULL
9	NULL
phia	NULL
,	NULL
PP	NULL
ments	NULL
]	NULL
.	NULL

N	NULL
Engl	NULL
J	NULL
Med	NULL
.	NULL

1997	NULL
;	NULL
337:453-458	NULL
.	NULL

Williams	NULL
&	NULL
Wilkins	NULL
;	NULL
1999:121-137	NULL
.	NULL

Lauder	NULL
1	NULL
.	NULL

Localization	NULL
of	NULL
immunoglobulin	NULL
light	NULL
4	NULL
.	NULL

Marafioti	NULL
T	NULL
,	NULL
Hummel	NULL
!	NULL

M	NULL
,	NULL
Foss	NULL
HD	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Hodgkin	NULL
14	NULL
.	NULL

Cordell	NULL
JL	NULL
,	NULL
Falini	NULL
B	NULL
,	NULL
Erber	NULL
WN	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Immuncen-	NULL
chain	NULL
mRNA	NULL
expression	NULL
in	NULL
Hodgkin	NULL
's	NULL
disease	NULL
by	NULL
and	NULL
Reed-Sternberg	NULL
cells	NULL
represent	NULL
an	NULL
expan-	NULL
zymatic	NULL
labeling	NULL
of	NULL
monoclonal	NULL
antibodies	NULL
using	NULL
in	NULL
situ	NULL
hybfrldlzatlon	NULL
.	NULL

J	NULL
Pathol	NULL
.	NULL

1991	NULL
;	NULL
164:37-40.	NULL
sion	NULL
of	NULL
a	NULL
single	NULL
clone	NULL
originating	NULL
from	NULL
a	NULL
germinal	NULL
immune	NULL
complexes	NULL
of	NULL
alkaline	NULL
phosphatase	NULL
and	NULL
27	NULL
.	NULL

Hell	NULL
K	NULL
,	NULL
Pringle	NULL
JH	NULL
,	NULL
Hansmann	NULL
ML	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Demon-center	NULL
B	NULL
cell	NULL
with	NULL
functional	NULL
immunoglobulin	NULL
gene	NULL
monoclonal	NULL
anti-alkaline	NULL
phosphatase	NULL
(	NULL
APAAP	NULL
stration	NULL
of	NULL
light	NULL
chain	NULL
mRNA	NULL
in	NULL
Hodgkin	NULL
's	NULL
disease	NULL
.	NULL

rearrangements	NULL
but	NULL
defective	NULL
immunoglobulin	NULL
complexes	NULL
}	NULL
.	NULL

J	NULL
Histochem	NULL
Cytochem	NULL
.	NULL

1984	NULL
;	NULL
32	NULL
:	NULL
J	NULL
Pathol	NULL
.	NULL

1993	NULL
;	NULL
171:137-143.	NULL
transcription	NULL
.	NULL

Blood	NULL
.	NULL

2000	NULL
;	NULL
95:1443-1450	NULL
.	NULL

219-229	NULL
,	NULL
28.	NULL
von	NULL
Wasielewski	NULL
R	NULL
,	NULL
Werner	NULL
M	NULL
,	NULL
Fischer	NULL
R	NULL
,	NULL
et	NULL
al	NULL
.	NULL

5	NULL
.	NULL

Bréunin_ger	NULL
A	NULL
,	NULL
Kuppers	NULL
R	NULL
,	NULL
Strickler	NULL
JG	NULL
,	NULL
Wacker	NULL
15	NULL
.	NULL

Foss	NULL
HD	NULL
,	NULL
Herbst	NULL
H	NULL
,	NULL
Oelmann	NULL
E	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Lympho-	NULL
Pymphozytf-plzedqmlilant	NULL
Fogglﬂré	NULL
’	NULL
gglsegsean	NULL
HH	NULL
,	NULL
Rajewsky	NULL
K	NULL
,	NULL
Hansmann	NULL
ML	NULL
.	NULL

Hodgkin	NULL
and	NULL
toxin	NULL
,	NULL
tumour	NULL
necrosis	NULL
factor	NULL
and	NULL
interleukin-6	NULL
iMUno	NULL
e	NULL
b	NULL
ana	NULL
Yee	NULL
0	NULL
reviewe	NULL
Reed-Sternberg	NULL
cells	NULL
in	NULL
lymphocyte	NULL
predominant	NULL
;	NULL
j	NULL
;	NULL
Hodgkin	NULL
's	NULL
disease	NULL
cases	NULL
from	NULL
the	NULL
German	NULL
in	NULL
di	NULL
;	NULL
gene	NULL
transcripts	NULL
are	NULL
present	NULL
in	NULL
Hodgkin	NULL
and	NULL
Hodgkin	NULL
Study	NULL
Group	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
.	NULL

1997	NULL
;	NULL
150	NULL
:	NULL
Hodg_k|n	NULL
disease	NULL
represent	NULL
clonal	NULL
populathns	NULL
of	NULL
Reed-Sternberg	NULL
cells	NULL
of	NULL
most	NULL
Hodgkin	NULL
's	NULL
disease	NULL
793-803	NULL
'	NULL
germinal	NULL
center-derived	NULL
tumor	NULL
B	NULL
cells	NULL
[	NULL
published	NULL
cases	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
.	NULL

1993	NULL
;	NULL
84:627-635	NULL
.	NULL

~000	NULL
.	NULL

20	NULL
,	NULL
f	NULL
erratum	NULL
appears	NULL
in	NULL
Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
U	NULL
S	NULL
A	NULL
R	NULL
,	NULL
.	NULL

h	NULL
29	NULL
.	NULL

Kippers	NULL
R.	NULL
Identifying	NULL
the	NULL
precursors	NULL
of	NULL
Hodgkin	NULL
1997	NULL
Dec	NULL
9	NULL
;	NULL
94	NULL
(	NULL
25	NULL
)	NULL
:14211	NULL
]	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
16	NULL
.	NULL

Wirth	NULL
T-	NULL
Priess	NULL
A	NULL
?	NULL

Annweiler	NULL
A	NULL
,	NULL
Zwilling	NULL
S	NULL
,	NULL
Oeler	NULL
and	NULL
Reed-Sternberg	NULL
cells	NULL
in	NULL
Hodgkin	NULL
's	NULL
disease	NULL
:	NULL
U	NULL
SA	NULL
.	NULL

1997	NULL
;	NULL
94:9337-9342	NULL
.	NULL

B	NULL
.	NULL

Multiple	NULL
Oct2	NULL
isoforms	NULL
are	NULL
generated	NULL
by	NULL
alter-	NULL
role	NULL
of	NULL
the	NULL
germinal	NULL
center	NULL
in	NULL
B-cell	NULL
lymphomagen-native	NULL
splicing	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

1991	NULL
;	NULL
19	NULL
:	NULL
i	NULL
i	NULL
i	NULL
6	NULL
.	NULL

Ohno	NULL
T	NULL
,	NULL
Stribley	NULL
JA	NULL
,	NULL
Wu	NULL
G	NULL
,	NULL
Hinrichs	NULL
SH	NULL
,	NULL
Weisen-	NULL
49.51	NULL
plicing	NULL
es.|s	NULL
.	NULL

J	NULL
Acquir	NULL
Immune	NULL
Defic	NULL
Syndr	NULL
.	NULL

1999	NULL
;	NULL
21	NULL
(	NULL
suppl	NULL
the	NULL
>	NULL
1	NULL
)	NULL
:574-S79	NULL
.	NULL

burger	NULL
DD	NULL
,	NULL
Chan	NULL
WC	NULL
.	NULL

Clonality	NULL
in	NULL
nodular	NULL
lym-	NULL
22	NULL
R	NULL
.	NULL

.	NULL

phocyte-predominant	NULL
Hodgkin	NULL
's	NULL
disease	NULL
[	NULL
see	NULL
17	NULL
.	NULL

Zwilling	NULL
S	NULL
,	NULL
Dieckmann	NULL
A	NULL
,	NULL
Pfisterer	NULL
P	NULL
,	NULL
Ange	NULL
!	NULL

P	NULL
,	NULL
30	NULL
.	NULL

Bargou	NULL
RC	NULL
,	NULL
Leng	NULL
C	NULL
,	NULL
Krappmann	NULL
D	NULL
,	NULL
gt	NULL
al	NULL
.	NULL

High-comments	NULL
]	NULL
.	NULL

N	NULL
Eng	NULL
!	NULL

J	NULL
Med	NULL
.	NULL

1997	NULL
;	NULL
337:459-465	NULL
.	NULL

Wirth	NULL
T.	NULL
Inducible	NULL
expression	NULL
and	NULL
phosphoryla-	NULL
level	NULL
nuclear	NULL
NF-kappa	NULL
B	NULL
and	NULL
Oct-2	NULL
is	NULL
a	NULL
common	NULL
M	NULL
.	NULL

tion	NULL
of	NULL
coactivator	NULL
BOB.1/O0BF.1	NULL
in	NULL
T	NULL
cells	NULL
[	NULL
see	NULL
feature	NULL
of	NULL
cultured	NULL
Hodgkin/Reed-Sternberg	NULL
cells	NULL
.	NULL

7	NULL
.	NULL

Kanzler	NULL
H	NULL
,	NULL
Kuppers	NULL
R	NULL
,	NULL
Hansmann	NULL
ML	NULL
,	NULL
Rajewsky	NULL
comments	NULL
]	NULL
.	NULL

Science	NULL
.	NULL

1997	NULL
;	NULL
277:221-225	NULL
.	NULL

Blood	NULL
.	NULL

1996:87:4340-4347	NULL
.	NULL

K.	NULL
Hodgkin	NULL
and	NULL
Reed-Sternberg	NULL
cells	NULL
in	NULL
1	NULL
.	NULL

Luo	NULL
Y	NULL
Roeder	NULL
RG	NULL
.	NULL

Cloning	NULL
,	NULL
f	NULL
ional	NULL
ch	NULL
Hodgkin	NULL
's	NULL
disease	NULL
represent	NULL
the	NULL
outgrowth	NULL
of	NULL
a	NULL
18	NULL
.	NULL

Konig	NULL
H	NULL
,	NULL
Pfisterer	NULL
P	NULL
,	NULL
Corcoran	NULL
LM	NULL
,	NULL
Wirth	NULL
T.	NULL
Identi-	NULL
__	NULL
31+	NULL
Luo	NULL
Y	NULL
,	NULL
Roeder	NULL
RG	NULL
.	NULL

Cloning	NULL
,	NULL
functional	NULL
character-dominant	NULL
tumor	NULL
clone	NULL
derived	NULL
from	NULL
(	NULL
crippled	NULL
)	NULL
ger-	NULL
fication	NULL
of	NULL
CD36	NULL
as	NULL
the	NULL
first	NULL
gene	NULL
dependent	NULL
on	NULL
ization	NULL
,	NULL
and	NULL
mechanism	NULL
of	NULL
action	NULL
of	NULL
the	NULL
B-cell-minal	NULL
center	NULL
B	NULL
cells	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
.	NULL

1996	NULL
;	NULL
184:1495-	NULL
the	NULL
B-cell	NULL
differentiation	NULL
factor	NULL
Oct-2	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

specific	NULL
transcriptional	NULL
coactivator	NULL
OCA-B	NULL
.	NULL

Mol	NULL
1505	NULL
'	NULL
1995:9:1598-1607	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

1995	NULL
;	NULL
15:4115-4124	NULL
.	NULL

LoD	NULL
.	NULL

,	NULL
.	NULL

.	NULL

32	NULL
.	NULL

Marafioti	NULL
T	NULL
,	NULL
Hummel	NULL
!	NULL

M	NULL
,	NULL
Anagnostopoulos	NULL
I	NULL
,	NULL
Foss	NULL
8	NULL
.	NULL

Kuppors	NULL
Pu	NULL
Koin	NULL
U	NULL
,	NULL
Hna	NULL
My	NULL
hte	NULL
©	NULL
99	NULL
.	NULL

Mik	NULL
P	NULL
_	NULL
MQ	NULL
MutD	NULL
SomH	NULL
Cla	NULL
heogiin	NULL
's	NULL
d	NULL
Cellular	NULL
origin	NULL
of	NULL
hurnan	NULL
B-cell	NULL
lymphomas	NULL
.	NULL
'	NULL

.	NULL

.	NULL

Po	NULL
``	NULL
ease	NULL
and	NULL
follicular	NULL
lymphoma	NULL
originating	NULL
from	NULL
the	NULL
N	NULL
Eng	NULL
!	NULL

J	NULL
Med	NULL
.	NULL

1999	NULL
;	NULL
341:1520-1529	NULL
.	NULL

Oct	NULL
!	NULL

and	NULL
Oct2	NULL
is	NULL
determined	NULL
by	NULL
additional	NULL
B	NULL
cell-	NULL
.	NULL

:	NULL
.	NULL

’	NULL
fic	NULL
activities	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

1994:13:1655-1663	NULL
same	NULL
germinal	NULL
center	NULL
B	NULL
cell	NULL
.	NULL

J	NULL
Clin	NULL
Oncol	NULL
.	NULL

1999	NULL
;	NULL
9	NULL
.	NULL

Chang	NULL
JF	NULL
,	NULL
Phillips	NULL
K	NULL
,	NULL
Lundback	NULL
T	NULL
,	NULL
Gstaiger	NULL
M	NULL
,	NULL
specific	NULL
activites	NULL
.	NULL

+1990	NULL
15:1009-1008	NULL
.	NULL

17:3804-3809	NULL
.	NULL

Ladbury	NULL
JE	NULL
,	NULL
Luisi	NULL
B.	NULL
Oct-1	NULL
POU	NULL
and	NULL
octamer	NULL
20	NULL
.	NULL

Pfisterer	NULL
P	NULL
,	NULL
Z\_Ni||ing	NULL
S	NULL
,	NULL
Hes	NULL
?	NULL

J	NULL
,	NULL
Wirth	NULL
T.	NULL
Functional	NULL
33	NULL
.	NULL

Brauninger	NULL
A	NULL
,	NULL
Hansmann	NULL
ML	NULL
,	NULL
Strickler	NULL
JG	NULL
,	NULL
et	NULL
al	NULL
.	NULL

DNA	NULL
cooperate	NULL
to	NULL
recognise	NULL
the	NULL
Bob-1	NULL
transcrip-	NULL
characterlzatlon	NULL
of	NULL
the	NULL
murine	NULL
homolog	NULL
of	NULL
Fhe	NULL
B	NULL
Identification	NULL
of	NULL
common	NULL
germinal-center	NULL
B-cell	NULL
tion	NULL
coactivator	NULL
via	NULL
induced	NULL
folding	NULL
.	NULL

J	NULL
Mol	NULL
Biol	NULL
.	NULL

cell-specific	NULL
coactivator	NULL
BOB.1/OBF.1	NULL
.	NULL

J	NULL
Biol	NULL
precursors	NULL
in	NULL
two	NULL
patients	NULL
with	NULL
both	NULL
Hodgkin	NULL
's	NULL
1999	NULL
;	NULL
288:941-952	NULL
.	NULL

Chem	NULL
.	NULL

1995	NULL
;	NULL
270:29870-29880.	NULL
disease	NULL
and	NULL
non-Hodgkin	NULL
's	NULL
lymphoma	NULL
[	NULL
see	NULL
com-10	NULL
.	NULL

Shah	NULL
PC	NULL
,	NULL
Bertolino	NULL
E	NULL
,	NULL
Singh	NULL
H.	NULL
Using	NULL
altered	NULL
21	NULL
.	NULL

Garvin	NULL
AJ	NULL
,	NULL
Spicer	NULL
SS	NULL
,	NULL
Parmley	NULL
RT	NULL
,	NULL
Munster	NULL
AM	NULL
.	NULL

ments	NULL
]	NULL
.	NULL

N	NULL
Engl	NULL
J	NULL
Med	NULL
.	NULL

1999	NULL
;	NULL
340:1239-1247.	NULL
specificity	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
mutants	NULL
to	NULL
analyze	NULL
Immunchistochemical	NULL
demonstration	NULL
of	NULL
IgG	NULL
in	NULL
34	NULL
.	NULL

Tang	NULL
H	NULL
,	NULL
Sharp	NULL
PA.	NULL
Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
regulation	NULL
of	NULL
immunoglobulin	NULL
gene	NULL
transcription	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

1997	NULL
;	NULL
16:7105-7117	NULL
.	NULL

Reed-Sternberg	NULL
and	NULL
other	NULL
cells	NULL
in	NULL
Hodgkin	NULL
's	NULL
disease	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
.	NULL

1974	NULL
;	NULL
139:1077-1083.	NULL
the	NULL
murine	NULL
3	NULL
'	NULL
IgH	NULL
enhancer	NULL
by	NULL
OCT-2	NULL
.	NULL

Immunity	NULL
.	NULL

1999	NULL
;	NULL
11:517-526	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
2001	NULL
97	NULL
:	NULL
496-501	NULL
doi:10.1182/blood.V97.2.496	NULL
Down-regulation	NULL
of	NULL
BOB.1/0BF.1	NULL
and	NULL
Oct2	NULL
in	NULL
classical	NULL
Hodgkin	NULL
disease	NULL
but	NULL
not	NULL
in	NULL
lymphocyte	NULL
predominant	NULL
Hodgkin	NULL
disease	NULL
correlates	NULL
with	NULL
immunoglobulin	NULL
transcription	NULL
4	NULL
QM	NULL
“	NULL
Caw	NULL
,	NULL
.	NULL

A	NULL
'	NULL
\se	NULL
@	NULL
.	NULL

®	NULL
``	NULL
Ctown®	NULL
@	NULL
``	NULL
20	NULL
Harald	NULL
Stein	NULL
,	NULL
Theresa	NULL
Marafioti	NULL
,	NULL
Hans-Dieter	NULL
Foss	NULL
,	NULL
Helmut	NULL
Laumen	NULL
,	NULL
Michael	NULL
Hummel	NULL
,	NULL
loannis	NULL
Anagnostopoulos	NULL
,	NULL
Thomas	NULL
Wirth	NULL
,	NULL
Gudrun	NULL
Demel	NULL
and	NULL
Brunangelo	NULL
Falini	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/97/2/496.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Gene	NULL
Expression	NULL
(	NULL
1086	NULL
articles	NULL
)	NULL
Neoplasia	NULL
(	NULL
4182	NULL
articles	NULL
)	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

